1.1    .................... moves to amend H. F. No. 2241 as follows:
1.2Delete everything after the enacting clause and insert:


1.6    The amounts shown in this section summarize direct appropriations, by fund, made
1.7in this article.

1.13    The sums shown in the columns marked "Appropriations" are appropriated to the
1.14agencies and for the purposes specified in this article. The appropriations are from the
1.15general fund, or another named fund, and are available for the fiscal years indicated
1.16for each purpose. The figures "2008" and "2009" used in this article mean that the
1.17appropriations listed under them are available for the fiscal year ending June 30, 2008, or
1.18June 30, 2009, respectively. "The first year" is fiscal year 2008. "The second year" is fiscal
1.19year 2009. "The biennium" is fiscal years 2008 and 2009. Appropriations for the fiscal
1.20year ending June 30, 2007, are effective the day following final enactment.
Available for the Year
Ending June 30

Subdivision 1.Total Appropriation
Appropriations by Fund
2.5Of this amount, $750,000 the first year
2.6and $750,000 the second year are onetime
2.7appropriations from the state's federal TANF
2.8block grant under Title I of Public Law
2.9Number 104-193. If the appropriation in
2.10either year is insufficient, the appropriation
2.11for the other year is available.
Subd. 2.Other Children and Economic
Assistance Grants
2.14Homeless and Runaway Youth. $3,500,000
2.15in the first year and $3,500,000 in the second
2.16year are for the Runaway and Homeless
2.17Youth Act under Minnesota Statutes, section
2.18256K.45. Funds shall be spent in each area
2.19of the continuum of care to ensure that
2.20programs are meeting the greatest need. The
2.21base is decreased by $2,000,000 each year in
2.22fiscal year 2010 and fiscal year 2011.
2.23Transitional Housing and Emergency
2.25(1) $750,000 each year from the federal
2.26TANF fund is for transitional housing
2.27programs under Minnesota Statutes, section
2.28256E.33. The TANF appropriations
2.29are onetime. The general fund base for
2.30transitional housing is increased by $422,000
2.31each year for the fiscal 2010-2011 biennium.
2.32Up to ten percent of this appropriation may
2.33be used for housing and services which
2.34extend beyond 24 months. $300,000 in each
2.35year of this amount is for grants for safe
3.1housing pilot projects for battered women
3.2and families in Anoka County, Houston
3.3County, and Beltrami County; and
3.4(2) $527,000 each year is added to the
3.5base for emergency services grants under
3.6Laws 1997, chapter 162, article 3, section
3.77. The base for emergency services grants
3.8is decreased each year by $300,000 in fiscal
3.9year 2010 and fiscal year 2011.
3.10Foodshelf Programs. $575,000 each year
3.11is added to the base for foodshelf programs
3.12under Minnesota Statutes, section 256E.34.
3.13The base is decreased by $250,000 each year
3.14in fiscal year 2010 and fiscal year 2011.
3.15Long-term Homeless Services. $2,440,000
3.16each year is added to the base for the
3.17long-term homeless services under
3.18Minnesota Statutes, section 256K.26. The
3.19base is decreased by $1,000,000 each year in
3.20fiscal year 2010 and fiscal year 2011.
3.21Minnesota Community Action Grants.
3.22$1,500,000 each year is added to the base for
3.23the purposes of Minnesota community action
3.24grants under Minnesota Statutes, sections
3.25256E.30 to 256E.32. The base is reduced by
3.26$500,000 each year in fiscal year 2010 and
3.27fiscal year 2011.
3.28Tenant Hotline Services Program. $50,000
3.29each year is added to the base for a grant to
3.30HOME Line for the tenant hotline services
3.31program. This is a onetime appropriation.
Subd. 3.Children and Economic Assistance

3.34    Sec. 4. Minnesota Statutes 2006, section 256K.45, is amended by adding a subdivision
3.35to read:
4.1    Subd. 6. Funding. Any funds appropriated for this section may be expended
4.2on programs described under subdivisions 3 to 5, technical assistance, and capacity
4.3building. In addition, up to five percent of funds appropriated may be used for program
4.4administration and up to eight percent of funds appropriated may be used for the purpose
4.5of monitoring and evaluating runaway and homeless youth programs receiving funding
4.6under this section. Funding shall be directed to meet the greatest need, with a significant
4.7share of the funding focused on homeless youth providers in greater Minnesota.

4.9    (a) The commissioner of human services shall offer a request for proposals to
4.10identify a research and evaluation firm with experience working with:
4.11    (1) homeless youth providers;
4.12    (2) data; and
4.13    (3) the topics of housing, homelessness, and a continuum of care for youth.
4.14    (b) The research and evaluation firm identified under paragraph (a) shall monitor and
4.15evaluate the programs receiving funding under Minnesota Statutes, section 256K.45.


4.19The amounts shown in this section summarize direct appropriations, by fund, made
4.20in this article.
State Government Special
Health Care Access
Federal TANF

4.29    The sums shown in the columns marked "Appropriations" are appropriated to the
4.30agencies and for the purposes specified in this article. The appropriations are from the
4.31general fund, or another named fund, and are available for the fiscal years indicated
4.32for each purpose. The figures "2008" and "2009" used in this article mean that the
4.33appropriations listed under them are available for the fiscal year ending June 30, 2008, or
4.34June 30, 2009, respectively. "The first year" is fiscal year 2008. "The second year" is fiscal
4.35year 2009. "The biennium" is fiscal years 2008 and 2009. Appropriations for the fiscal
4.36year ending June 30, 2007, are effective the day following final enactment.
Available for the Year
Ending June 30

Subdivision 1.Total Appropriation
Appropriations by Fund
State Government
Special Revenue
Health Care Access
Federal TANF
Subd. 2.Community and Family Health
Appropriations by Fund
State Government
Special Revenue
Health Care Access
Federal TANF
5.22TANF Appropriations. $5,088,000 of the
5.23TANF funds in the first year and $5,423,000
5.24in the second year are appropriated to
5.25the commissioner for home visiting and
5.26nutritional services listed under Minnesota
5.27Statutes, section 145.882, subdivision 7,
5.28clauses (6) and (7). Funding shall be
5.29distributed to community health boards based
5.30on Minnesota Statutes, section 145A.131,
5.31subdivision 1.
5.32Loan Forgiveness. $605,000 the first year
5.33and $775,000 the second year and thereafter
5.34are for the loan forgiveness program under
5.35Minnesota Statutes, section 144.1501. This
5.36funding is in addition to the loan forgiveness
5.37program base.
6.1MN ENABL. Base level funding for the MN
6.2ENABL program, under Minnesota Statutes,
6.3section 145.9255, is reduced by $220,000
6.4each year of the biennium beginning July 1,
6.6Positive Alternatives. Base level funding for
6.7the positive abortion alternatives program,
6.8under Minnesota Statutes, section 145.4235,
6.9is reduced by $1,400,000 each year of the
6.10biennium beginning July 1, 2007.
6.11Fetal Alcohol Spectrum Disorder. (a)
6.12$900,000 each year is added to the base for
6.13fetal alcohol spectrum disorder. On July 1
6.14each fiscal year, the portion of the general
6.15fund appropriation to the commissioner of
6.16health for fetal alcohol spectrum disorder
6.17administration and grants shall be transferred
6.18to a statewide organization that focuses
6.19solely on prevention of and intervention with
6.20fetal alcohol spectrum disorder as follows:
6.21(1) on July 1, 2007, $2,090,000; and
6.22(2) on July 2, 2008, and annually thereafter,
6.24(b) The money shall be used for prevention
6.25and intervention services and programs,
6.26including, but not limited to, community
6.27grants, professional education, public
6.28awareness, and diagnosis. The organization
6.29may retain $60,000 of the transferred money
6.30for administrative costs. The organization
6.31shall report to the commissioner annually
6.32by January 15 on the services and programs
6.33funded by the appropriation.
6.34Deaf or Hearing Loss Support. $100,000
6.35for the first year and $100,000 for the second
7.1year is for the purpose of providing family
7.2support and assistance to families with
7.3children who are deaf or have a hearing
7.4loss. The family support provided must
7.5include direct parent-to-parent assistance and
7.6information on communication, educational,
7.7and medical options. The commissioner
7.8may contract with a nonprofit organization
7.9that has the ability to provide these services
7.10throughout the state.
7.11HIV Information. $80,000 each year
7.12is to fund a community-based nonprofit
7.13organization with demonstrated capacity to
7.14operate a statewide HIV information and
7.15referral service using telephone, Internet, and
7.16other appropriate technologies.
7.17Heart Disease and Stroke Prevention.
7.18$200,000 is appropriated in the first year for
7.19the heart disease and stroke prevention unit
7.20of the Department of Health to fund data
7.21collection and other activities to improve
7.22cardiovascular health and reduce the burden
7.23of heart disease and stroke in Minnesota.
7.24This is a onetime appropriation.
7.25Lead Hazard Reduction. $250,000 is
7.26appropriated in the first year of the biennium
7.27for a grant to a nonprofit organization
7.28operating the CLEARCorps to conduct a
7.29pilot project to determine the incidence of
7.30lead hazards in pre-1978 rental property.
7.31Any balance in the first year does not cancel
7.32but is available in the second year.
7.33Family Planning Grants. $1,000,000 each
7.34year is for family planning grants under
7.35Minnesota Statutes, section 145.925.
8.1Minnesota Birth Defects Information
8.2System. $750,000 each year is to maintain
8.3the birth defects information system that was
8.4established by Minnesota Statutes, section
8.6Bright Smiles Pilot Project. (a) $384,000
8.7in the first year and $50,000 in the second
8.8year is to fund a grant for the Bright Smiles
8.9pilot project.
8.10(b) Of these amounts, $50,000 each year is to
8.11fund a dental health coordinator position.
8.12(c) The commissioner of health shall
8.13establish a pilot project to fund a Bright
8.14Smiles program designed to increase access
8.15to oral health care for low-income and
8.16immigrant children, ages birth to five
8.17years, and their families and to build the
8.18knowledge and ability of parents to care
8.19for the oral health of their children. Under
8.20this pilot project, a Bright Smiles program
8.21shall serve the medically underserved areas
8.22in Minneapolis and the Bemidji area, as
8.23determined by the commissioner of health.
8.24(d) A grant shall be used to fund costs related
8.25to improving oral health outreach, education,
8.26screening, and access to care for families
8.27with children, ages birth to five years.
8.28(e) Grant applicants shall submit to
8.29the commissioner a written plan that
8.30demonstrates the ability to provide the
8.32(1) new programs or continued expansion
8.33of current access programs that have
8.34demonstrated success in providing dental
9.1services in underserved areas of Minneapolis
9.2and the Bemidji area;
9.3(2) programs for screening children entering
9.4the Minneapolis and the Bemidji area public
9.5school systems and facilitating access to care
9.6for their families;
9.7(3) programs testing new models of care
9.8that are sensitive to cultural needs of the
9.10(4) programs creating new educational
9.11campaigns that inform individuals of the
9.12importance of good oral health and the
9.13link between dental diseases, overall health
9.14status, and success in school; and
9.15(5) programs testing new delivery models
9.16by creating partnerships between local early
9.17childhood and school-age education and
9.18community clinic dental providers.
9.19(f) Qualified applicants are partnerships
9.20among early childhood experts, Minneapolis
9.21or Bemidji area public schools, and nonprofit
9.22clinics that are established to provide health
9.23services to low-income patients, provide
9.24preventive and dental care services, and
9.25utilize a sliding-scale fee or other method of
9.26providing charity care that ensures that no
9.27person is denied services because of inability
9.28to pay.
9.29(g) Applicants shall submit to the
9.30commissioner an application and supporting
9.31documentation, in the form and manner
9.32specified by the commissioner. Applicants
9.33must be able to provide culturally appropriate
9.34outreach, screenings, and access to dental
9.35care for children, ages birth to five years,
10.1their parents, and pregnant women most at
10.2risk of poor oral health due to lack of access
10.3to dental care. Applicants must also meet the
10.4following criteria:
10.5(1) have the potential to successfully increase
10.6access to families with children, ages birth
10.7to five years;
10.8(2) incorporate quality program evaluation;
10.9(3) maximize use of grant funds; and
10.10(4) have experience in providing services to
10.11the target populations of this program.
10.12(h) The commissioner shall evaluate the
10.13effectiveness of this pilot program on the
10.14oral health of children and their families and
10.15report to the house of representatives and
10.16senate committees with jurisdiction over
10.17public health policy and finance by January
10.181, 2009, with recommendations as to how to
10.19develop programs throughout Minnesota that
10.20provide education and access to oral health
10.21care for low-income and immigrant children.
10.22Suicide prevention programs. $600,000
10.23each year is to fund the suicide prevention
10.24program and to administer the grants for
10.25institutions of higher education in the state
10.26of Minnesota to coordinate implementation
10.27of youth suicide early intervention and
10.28prevention strategies. The base for fiscal
10.29years 2010 and 2011 is reduced by $300,000.
Subd. 3.Health Protection
Appropriations by Fund
State Government
Special Revenue
11.1Pandemic Influenza Preparedness. Of
11.2the general fund appropriation to the
11.3commissioner, $4,088,000 in fiscal year 2008
11.4is for preparation, planning, and response
11.5to a pandemic influenza outbreak. This
11.6appropriation is available until June 30, 2009.
11.7Base funding for the 2010-2011 biennium is
11.8$0 each fiscal year.
11.9Environmental Health Tracking and
11.10Biomonitoring. (a) $700,000 in each
11.11year is to the Department of Health for
11.12the environmental health tracking and
11.13biomonitoring program. The base for fiscal
11.14year 2010 and fiscal year 2011 is increased
11.15by $300,000 each year.
11.16(b) $300,000 each year is from the
11.17environmental fund to the Pollution Control
11.18Agency for transfer to the Department
11.19of Health for the health tracking and
11.20biomonitoring program. The base for the
11.21environmental fund is $0 in fiscal year 2010
11.22and after.
11.23AIDS Prevention Initiative Focusing
11.24on African-born Residents. $300,000 in
11.252008 is for an AIDS prevention initiative
11.26focusing on African-born residents. This
11.27appropriation is a onetime appropriation
11.28and shall not become part of the base-level
11.29funding for the 2008-2009 biennium.
11.30The commissioner of health shall award
11.31grants in accordance with Minnesota Statutes,
11.32section 145.924, paragraph (b), for a public
11.33education and awareness campaign targeting
11.34communities of African-born Minnesota
11.35residents. The grants shall be designed to
12.1promote knowledge and understanding about
12.2HIV and to increase knowledge in order
12.3to eliminate and reduce the risk for HIV
12.4infection; to encourage screening and testing
12.5for HIV; and to link individuals to public
12.6health and health care resources. The grants
12.7must be awarded to collaborative efforts that
12.8bring together nonprofit community-based
12.9groups with demonstrated experience in
12.10addressing the public health, health care,
12.11and social service needs of African-born
12.13Water Level Standard for Atrazine.
12.14$200,000 in 2008 is for a study relating to
12.15atrazine health risk limit standards under
12.16Minnesota Statutes, section 144.355. This is
12.17a onetime appropriation.
12.18Arsenic Health Risk Standard. $920,000 in
12.19the first year and $461,000 in the second year
12.20is to fund the study relating to arsenic health
12.21risk standards, under Minnesota Statutes,
12.22section 144.967.
12.23Lindane and Bisphenol-A Studies.
12.24$114,000 in the first year is for the Lindane
12.25committee and the study of bisphenol-A,
12.26under Minnesota Statutes, section 325.72.
12.27This is a onetime appropriation.
12.28Decabromodiphenyl Ether Study.
12.29$118,000 in the first year is for transfer to the
12.30commissioner of the pollution control agency
12.31for the study of decabromodiphenyl ether
12.32under Minnesota Statutes, section 325E.387.
12.33This is a onetime appropriation.
12.34Radiation Study. $45,000 in the first year
12.35from the general fund and $15,000 in the
13.1first year from the state government special
13.2revenue fund are for the radiation study in
13.3section 60. This is a onetime appropriation.
13.4Lead Abatement. $1,500,000 each year is
13.5for changes in lead abatement requirements.
13.6A portion of this amount may be used to
13.7reimburse local governments for costs of
13.8implementing the new requirements.
13.9Cancer Surveillance. $948,000 in the first
13.10year is for a cancer surveillance pilot project
13.11integrating information about environmental
13.12exposure to toxic substances into the cancer
13.13surveillance system. The pilot shall include,
13.14with the patient's informed consent, an
13.15interview about possible exposures to toxic
13.16substances in the environment, as well
13.17as residential, occupational, and military
13.18history. The commissioner shall report to the
13.19legislature by January 15, 2009, regarding
13.20preliminary findings, recommendations, and
13.21a cost estimate for collecting risk information
13.22on a statewide basis. This is a onetime
13.24Water Treatment. $40,000 in the first year
13.25is for water treatment.
13.26Environmental Justice Mapping. $137,000
13.27in the first year and $53,000 in the second
13.28year is for environmental justice mapping.
Subd. 4.Minority and Multicultural Health
Appropriations by Fund
Federal TANF
13.33TANF Appropriations. $2,683,000 of the
13.34TANF funds in the first year and $2,998,000
13.35in the second year are appropriated to
14.1the commissioner for home visiting and
14.2nutritional services listed under Minnesota
14.3Statutes, section 145.882, subdivision 7,
14.4clauses (6) and (7). Funding shall be
14.5distributed to tribal governments based
14.6on Minnesota Statutes, section 145A.14,
14.7subdivision 2, paragraph (b).
Subd. 5.Administrative Support Services
Appropriations by Fund
Health Care Access
14.12Disease Surveillance. $2,000,000 each fiscal
14.13year is for redesigning and implementing
14.14coordinated and modern disease surveillance
14.15systems for the department. Base level
14.16funding for the 2012-2013 biennium will be
14.17$600,000 each fiscal year for maintaining
14.18and operating the systems.

14.21Repair and Betterment. Of this
14.22appropriation, $4,000,000 in fiscal year
14.232008 and $4,000,000 in fiscal year 2009
14.24are to be used for repair, maintenance,
14.25rehabilitation, and betterment activities at
14.26facilities statewide.
14.27Base Adjustment. The general fund base is
14.28decreased by $2,000,000 in fiscal year 2010
14.29and $2,000,000 in fiscal year 2011.

Subdivision 1.Total Appropriation; State
Government Special Revenue Fund
14.33The commissioner of finance shall not permit
14.34the allotment, encumbrance, or expenditure
14.35of money appropriated in this section in
15.1excess of the anticipated biennial revenues
15.2or accumulated surplus revenues from fees
15.3collected by the boards.
Subd. 2.Board of Chiropractic Examiners
Subd. 3.Board of Dentistry
Subd. 4.Board of Dietetic and Nutrition
15.8Base Adjustment. Of this appropriation in
15.9fiscal year 2009, $14,000 is onetime.
Subd. 5.Board of Marriage and Family
15.12Base Adjustment. Of this appropriation in
15.13fiscal year 2009, $17,000 is onetime.
Subd. 6.Board of Medical Practice
Subd. 7.Board of Nursing
Subd. 8.Board of Nursing Home
15.18Administrative Services Unit. Of this
15.19appropriation, $430,000 in fiscal year
15.202008 and $439,000 in fiscal year 2009 are
15.21for the administrative services unit. The
15.22administrative services unit may receive
15.23and expend reimbursements for services
15.24performed by other agencies.
Subd. 9.Board of Optometry
15.26Base Adjustment. Of this appropriation in
15.27fiscal year 2009, $13,000 is onetime.
Subd. 10.Board of Pharmacy
15.29Base Adjustment. Of this appropriation in
15.30fiscal year 2009, $29,000 is onetime.
Subd. 11.Board of Physical Therapy
Subd. 12.Board of Podiatry
16.1Base Adjustment. Of this appropriation in
16.2fiscal year 2009, $7,000 is onetime.
Subd. 13.Board of Psychology
Subd. 14.Board of Social Work
Subd. 15.Board of Veterinary Medicine
Subd. 16.Board of Behavioral Health and

Appropriations by Fund
State Government
Special Revenue
16.15Regional Emergency Medical Services
16.16Programs. $400,000 each year is for
16.17regional emergency medical services
16.18programs, to be distributed equally to the
16.19eight emergency medical service regions.
16.20This amount shall be added to the base
16.21funding. Notwithstanding Minnesota
16.22Statutes, section 144E.50, 100 percent of
16.23the appropriation shall be passed on to the
16.24emergency medical service regions.
16.25Health Professional Services Program.
16.26$687,000 in fiscal year 2008 and $704,000 in
16.27fiscal year 2009 from the state government
16.28special revenue fund are for the health
16.29professional services program.

16.31Options Too. (a) $75,000 for the first
16.32year and $75,000 for the second year are
16.33to continue the work of the Options Too
16.34disability services interagency work group
16.35established under Laws 2005, First Special
17.1Session chapter 4, article 7, section 57.
17.2Funds shall be used to monitor and assist the
17.3work group and the Options Too Steering
17.4Committee in the implementation of the
17.5recommendations in the Options Too report
17.6dated February 15, 2007.
17.7(b) For purposes of this section, the Options
17.8Too Steering Committee shall consist of the
17.9following members:
17.10(1) a representative from the Minnesota
17.11Housing Finance Agency;
17.12(2) a representative from the Minnesota State
17.13Council on Disability;
17.14(3) a representative from the Department of
17.15Veterans Affairs;
17.16(4) a representative from the Department of
17.18(5) a representative from the Department of
17.19Human Services; and
17.20(6) representatives from interested
17.21stakeholders including counties, local
17.22public housing authorities, the Metropolitan
17.23Council, disability service providers, and
17.24disability advocacy organizations who are
17.25appointed by the Minnesota State Council on
17.26Disability for two-year terms.
17.27(c) Notwithstanding Laws 2005, First Special
17.28Session chapter 4, article 7, section 57, the
17.29interagency work group shall be administered
17.30by the Minnesota Housing Finance Agency,
17.31the Minnesota State Council on Disability,
17.32Department of Human Services, and the
17.33Department of Transportation.
18.1(d) The Options Too Steering Committee
18.2shall report to the chairs of the health
18.3and human services policy and finance
18.4committees of the senate and house of
18.5representatives by October 15, 2007, and
18.6October 15, 2008, on the continued progress
18.7of the work group towards implementing the
18.8recommendations in the Options Too report
18.9dated February 15, 2007.



18.14    Sec. 10. Minnesota Statutes 2006, section 13.3806, is amended by adding a subdivision
18.15to read:
18.16    Subd. 21. Birth defects registry system. Data on individuals collected by the
18.17birth defects registry system are private data on individuals and classified pursuant to
18.18section 144.2215.

18.19    Sec. 11. Minnesota Statutes 2006, section 103I.101, subdivision 6, is amended to read:
18.20    Subd. 6. Fees for variances. The commissioner shall charge a nonrefundable
18.21application fee of $175 $215 to cover the administrative cost of processing a request for a
18.22variance or modification of rules adopted by the commissioner under this chapter.
18.23EFFECTIVE DATE.This section is effective July 1, 2008.

18.24    Sec. 12. Minnesota Statutes 2006, section 103I.208, subdivision 1, is amended to read:
18.25    Subdivision 1. Well notification fee. The well notification fee to be paid by a
18.26property owner is:
18.27    (1) for a new water supply well, $175 $215, which includes the state core function
18.29    (2) for a well sealing, $35 $50 for each well, which includes the state core function
18.30fee, except that for monitoring wells constructed on a single property, having depths
18.31within a 25 foot range, and sealed within 48 hours of start of construction, a single fee of
18.32$35 $50; and
18.33    (3) for construction of a dewatering well, $175 $215, which includes the state core
18.34function fee, for each dewatering well except a dewatering project comprising five or
19.1more dewatering wells shall be assessed a single fee of $875 $1,075 for the dewatering
19.2wells recorded on the notification.
19.3EFFECTIVE DATE.This section is effective July 1, 2008.

19.4    Sec. 13. Minnesota Statutes 2006, section 103I.208, subdivision 2, is amended to read:
19.5    Subd. 2. Permit fee. The permit fee to be paid by a property owner is:
19.6    (1) for a water supply well that is not in use under a maintenance permit, $150 $175
19.8    (2) for construction of a monitoring well, $175 $215, which includes the state
19.9core function fee;
19.10    (3) for a monitoring well that is unsealed under a maintenance permit, $150 $175
19.12    (4) for monitoring wells used as a leak detection device at a single motor fuel retail
19.13outlet, a single petroleum bulk storage site excluding tank farms, or a single agricultural
19.14chemical facility site, the construction permit fee is $175 $215, which includes the state
19.15core function fee, per site regardless of the number of wells constructed on the site, and
19.16the annual fee for a maintenance permit for unsealed monitoring wells is $150 $175 per
19.17site regardless of the number of monitoring wells located on site;
19.18    (5) for a groundwater thermal exchange device, in addition to the notification fee for
19.19water supply wells, $175 $215, which includes the state core function fee;
19.20    (6) for a vertical heat exchanger, $175 $215;
19.21    (7) for a dewatering well that is unsealed under a maintenance permit, $150 $175
19.22annually for each dewatering well, except a dewatering project comprising more than five
19.23dewatering wells shall be issued a single permit for $750 $875 annually for dewatering
19.24wells recorded on the permit; and
19.25    (8) for an elevator boring, $175 $215 for each boring.
19.26EFFECTIVE DATE.This section is effective July 1, 2008.

19.27    Sec. 14. Minnesota Statutes 2006, section 103I.235, subdivision 1, is amended to read:
19.28    Subdivision 1. Disclosure of wells to buyer. (a) Before signing an agreement to
19.29sell or transfer real property, the seller must disclose in writing to the buyer information
19.30about the status and location of all known wells on the property, by delivering to the buyer
19.31either a statement by the seller that the seller does not know of any wells on the property,
19.32or a disclosure statement indicating the legal description and county, and a map drawn
19.33from available information showing the location of each well to the extent practicable.
19.34In the disclosure statement, the seller must indicate, for each well, whether the well is in
19.35use, not in use, or sealed.
20.1    (b) At the time of closing of the sale, the disclosure statement information, name and
20.2mailing address of the buyer, and the quartile, section, township, and range in which each
20.3well is located must be provided on a well disclosure certificate signed by the seller or a
20.4person authorized to act on behalf of the seller.
20.5    (c) A well disclosure certificate need not be provided if the seller does not know
20.6of any wells on the property and the deed or other instrument of conveyance contains
20.7the statement: "The Seller certifies that the Seller does not know of any wells on the
20.8described real property."
20.9    (d) If a deed is given pursuant to a contract for deed, the well disclosure certificate
20.10required by this subdivision shall be signed by the buyer or a person authorized to act on
20.11behalf of the buyer. If the buyer knows of no wells on the property, a well disclosure
20.12certificate is not required if the following statement appears on the deed followed by the
20.13signature of the grantee or, if there is more than one grantee, the signature of at least one
20.14of the grantees: "The Grantee certifies that the Grantee does not know of any wells on the
20.15described real property." The statement and signature of the grantee may be on the front
20.16or back of the deed or on an attached sheet and an acknowledgment of the statement by
20.17the grantee is not required for the deed to be recordable.
20.18    (e) This subdivision does not apply to the sale, exchange, or transfer of real property:
20.19    (1) that consists solely of a sale or transfer of severed mineral interests; or
20.20    (2) that consists of an individual condominium unit as described in chapters 515
20.21and 515B.
20.22    (f) For an area owned in common under chapter 515 or 515B the association or other
20.23responsible person must report to the commissioner by July 1, 1992, the location and
20.24status of all wells in the common area. The association or other responsible person must
20.25notify the commissioner within 30 days of any change in the reported status of wells.
20.26    (g) For real property sold by the state under section 92.67, the lessee at the time of
20.27the sale is responsible for compliance with this subdivision.
20.28    (h) If the seller fails to provide a required well disclosure certificate, the buyer, or
20.29a person authorized to act on behalf of the buyer, may sign a well disclosure certificate
20.30based on the information provided on the disclosure statement required by this section
20.31or based on other available information.
20.32    (i) A county recorder or registrar of titles may not record a deed or other instrument
20.33of conveyance dated after October 31, 1990, for which a certificate of value is required
20.34under section 272.115, or any deed or other instrument of conveyance dated after October
20.3531, 1990, from a governmental body exempt from the payment of state deed tax, unless
20.36the deed or other instrument of conveyance contains the statement made in accordance
21.1with paragraph (c) or (d) or is accompanied by the well disclosure certificate containing all
21.2the information required by paragraph (b) or (d). The county recorder or registrar of titles
21.3must not accept a certificate unless it contains all the required information. The county
21.4recorder or registrar of titles shall note on each deed or other instrument of conveyance
21.5accompanied by a well disclosure certificate that the well disclosure certificate was
21.6received. The notation must include the statement "No wells on property" if the disclosure
21.7certificate states there are no wells on the property. The well disclosure certificate shall not
21.8be filed or recorded in the records maintained by the county recorder or registrar of titles.
21.9After noting "No wells on property" on the deed or other instrument of conveyance, the
21.10county recorder or registrar of titles shall destroy or return to the buyer the well disclosure
21.11certificate. The county recorder or registrar of titles shall collect from the buyer or the
21.12person seeking to record a deed or other instrument of conveyance, a fee of $40 $45
21.13for receipt of a completed well disclosure certificate. By the tenth day of each month,
21.14the county recorder or registrar of titles shall transmit the well disclosure certificates
21.15to the commissioner of health. By the tenth day after the end of each calendar quarter,
21.16the county recorder or registrar of titles shall transmit to the commissioner of health
21.17$32.50 $37.50 of the fee for each well disclosure certificate received during the quarter.
21.18The commissioner shall maintain the well disclosure certificate for at least six years. The
21.19commissioner may store the certificate as an electronic image. A copy of that image
21.20shall be as valid as the original.
21.21    (j) No new well disclosure certificate is required under this subdivision if the buyer
21.22or seller, or a person authorized to act on behalf of the buyer or seller, certifies on the deed
21.23or other instrument of conveyance that the status and number of wells on the property
21.24have not changed since the last previously filed well disclosure certificate. The following
21.25statement, if followed by the signature of the person making the statement, is sufficient
21.26to comply with the certification requirement of this paragraph: "I am familiar with the
21.27property described in this instrument and I certify that the status and number of wells on
21.28the described real property have not changed since the last previously filed well disclosure
21.29certificate." The certification and signature may be on the front or back of the deed or on
21.30an attached sheet and an acknowledgment of the statement is not required for the deed or
21.31other instrument of conveyance to be recordable.
21.32    (k) The commissioner in consultation with county recorders shall prescribe the form
21.33for a well disclosure certificate and provide well disclosure certificate forms to county
21.34recorders and registrars of titles and other interested persons.
21.35    (l) Failure to comply with a requirement of this subdivision does not impair:
22.1    (1) the validity of a deed or other instrument of conveyance as between the parties
22.2to the deed or instrument or as to any other person who otherwise would be bound by
22.3the deed or instrument; or
22.4    (2) the record, as notice, of any deed or other instrument of conveyance accepted for
22.5filing or recording contrary to the provisions of this subdivision.

22.6    Sec. 15. Minnesota Statutes 2006, section 144.123, is amended to read:
22.9    Subdivision 1. Who must pay. Except for the limitation contained in this section,
22.10the commissioner of health shall charge a handling fee for each specimen submitted to
22.11the Department of Health for analysis for diagnostic purposes by any hospital, private
22.12laboratory, private clinic, or physician. No fee shall be charged to any entity which
22.13receives direct or indirect financial assistance from state or federal funds administered by
22.14the Department of Health, including any public health department, nonprofit community
22.15clinic, venereal sexually transmitted disease clinic, family planning clinic, or similar
22.16entity. No fee will be charged for any biological materials submitted to the Department
22.17of Health as a requirement of Minnesota Rules, part 4605.7040, or for those biological
22.18materials requested by the department to gather information for disease prevention or
22.19control purposes. The commissioner of health may establish by rule other exceptions to
22.20the handling fee as may be necessary to gather information for epidemiologic purposes
22.21protect the public's health. All fees collected pursuant to this section shall be deposited in
22.22the state treasury and credited to the state government special revenue fund.
22.23    Subd. 2. Rules for Fee amounts. The commissioner of health shall promulgate
22.24rules, in accordance with chapter 14, which shall specify the amount of the charge a
22.25handling fee prescribed in subdivision 1. The fee shall approximate the costs to the
22.26department of handling specimens including reporting, postage, specimen kit preparation,
22.27and overhead costs. The fee prescribed in subdivision 1 shall be $15 $25 per specimen
22.28until the commissioner promulgates rules pursuant to this subdivision.

22.29    Sec. 16. Minnesota Statutes 2006, section 144.125, is amended to read:
22.32    Subdivision 1. Duty to perform testing. It is the duty of (1) the administrative
22.33officer or other person in charge of each institution caring for infants 28 days or less
22.34of age, (2) the person required in pursuance of the provisions of section 144.215,
22.35to register the birth of a child, or (3) the nurse midwife or midwife in attendance at
23.1the birth, to arrange to have administered to every infant or child in its care tests for
23.2heritable and congenital disorders according to subdivision 2 and rules prescribed by
23.3the state commissioner of health. Testing and the recording and reporting of test results
23.4shall be performed at the times and in the manner prescribed by the commissioner of
23.5health. The commissioner shall charge laboratory service fees a fee so that the total of
23.6fees collected will approximate the costs of conducting the tests and implementing and
23.7maintaining a system to follow-up infants with heritable or congenital disorders. The
23.8laboratory service fee is $61 $81 per specimen. Costs associated with capital expenditures
23.9and the development of new procedures may be prorated over a three-year period when
23.10calculating the amount of the fees.
23.11    Subd. 2. Determination of tests to be administered. The commissioner shall
23.12periodically revise the list of tests to be administered for determining the presence of a
23.13heritable or congenital disorder. Revisions to the list shall reflect advances in medical
23.14science, new and improved testing methods, or other factors that will improve the public
23.15health. In determining whether a test must be administered, the commissioner shall take
23.16into consideration the adequacy of laboratory analytical methods to detect the heritable
23.17or congenital disorder, the ability to treat or prevent medical conditions caused by the
23.18heritable or congenital disorder, and the severity of the medical conditions caused by the
23.19heritable or congenital disorder. The list of tests to be performed may be revised if the
23.20changes are recommended by the advisory committee established under section 144.1255,
23.21approved by the commissioner, and published in the State Register. The revision is
23.22exempt from the rulemaking requirements in chapter 14, and sections 14.385 and 14.386
23.23do not apply.
23.24    Subd. 3. Objection of parents to test. Persons with a duty to perform testing under
23.25subdivision 1 shall advise parents of infants (1) that the blood or tissue samples used to
23.26perform testing thereunder as well as the results of such testing may be retained by the
23.27Department of Health, (2) the benefit of retaining the blood or tissue sample, and (3) that
23.28the following options are available to them with respect to the testing: (i) to decline to
23.29have the tests, or (ii) to elect to have the tests but to require that all blood samples and
23.30records of test results be destroyed within 24 months of the testing. If the parents of
23.31an infant object in writing to testing for heritable and congenital disorders or elect to
23.32require that blood samples and test results be destroyed, the objection or election shall
23.33be recorded on a form that is signed by a parent or legal guardian and made part of the
23.34infant's medical record. A written objection exempts an infant from the requirements of
23.35this section and section 144.128.

24.1    Sec. 17. [144.355] WATER LEVEL STANDARD FOR ATRAZINE.
24.2    (a) The Department of Health in consultation with the Pollution Control Agency
24.3shall set atrazine drinking water standards for the health risk limit in private wells and the
24.4maximum contaminant level in public water systems at 3 ppb to comply with the federal
24.5standard determined by the United States Environmental Protection Agency.
24.6    (b) By December 31, 2007, the Department of Health in consultation with the
24.7Pollution Control Agency shall use current scientific evidence to set the drinking
24.8water standards for the health risk limit of atrazine in private wells and the maximum
24.9contaminant level of atrazine in public water systems at a level not to exceed 1 ppb
24.10to reflect the requirements in section 144.0751 to adequately protect the health of a
24.11developing fetus, infant, and child which requires a higher level of care due to fetal, infant,
24.12and child development.
24.13EFFECTIVE DATE.This section is effective the day following final enactment.

24.14    Sec. 18. Minnesota Statutes 2006, section 144.9501, is amended by adding a
24.15subdivision to read:
24.16    Subd. 11a. Filter paper test. A "filter paper test" means a test for preserving and
24.17testing blood specimens for lead that involves preserving patient blood specimens in the
24.18form of blood drops spotted on filter paper.

24.19    Sec. 19. Minnesota Statutes 2006, section 144.9502, subdivision 3, is amended to read:
24.20    Subd. 3. Reports of blood lead analysis required. (a) Every hospital, medical
24.21clinic, medical laboratory, other facility, or individual performing blood lead analysis shall
24.22report the results after the analysis of each specimen analyzed, for both capillary, filter
24.23paper test, and venous specimens, and epidemiologic information required in this section
24.24to the commissioner of health, within the time frames set forth in clauses (1) and (2):
24.25    (1) within two working days by telephone, fax, or electronic transmission, with
24.26written or electronic confirmation within one month, for a venous or filter paper test
24.27blood lead level equal to or greater than 15 ten micrograms of lead per deciliter of whole
24.28blood; or
24.29    (2) within one month in writing or by electronic transmission, for any capillary, or
24.30filter paper test, result or for a venous blood lead level less than 15 ten micrograms of
24.31lead per deciliter of whole blood.
24.32    (b) If a blood lead analysis is performed outside of Minnesota and the facility
24.33performing the analysis does not report the blood lead analysis results and epidemiological
24.34information required in this section to the commissioner, the provider who collected the
25.1blood specimen must satisfy the reporting requirements of this section. For purposes of
25.2this section, "provider" has the meaning given in section 62D.02, subdivision 9.
25.3    (c) The commissioner shall coordinate with hospitals, medical clinics, medical
25.4laboratories, and other facilities performing blood lead analysis to develop a universal
25.5reporting form and mechanism.

25.6    Sec. 20. Minnesota Statutes 2006, section 144.9502, subdivision 4, is amended to read:
25.7    Subd. 4. Blood lead analyses and epidemiologic information. The blood lead
25.8analysis reports required in this section must specify:
25.9    (1) whether the specimen was collected as a capillary, filter paper test, or venous
25.11    (2) the date the sample was collected;
25.12    (3) the results of the blood lead analysis;
25.13    (4) the date the sample was analyzed;
25.14    (5) the method of analysis used;
25.15    (6) the full name, address, and phone number of the laboratory performing the
25.17    (7) the full name, address, and phone number of the physician or facility requesting
25.18the analysis;
25.19    (8) the full name, address, and phone number of the person with the blood lead level,
25.20and the person's birthdate, gender, and race.

25.21    Sec. 21. Minnesota Statutes 2006, section 144.9502, subdivision 8, is amended to read:
25.22    Subd. 8. Laboratory standards. (a) A laboratory performing blood lead analysis
25.23shall use methods that:
25.24    (1) meet or exceed the proficiency standards established in the federal Clinical
25.25Laboratory Improvement Regulations, Code of Federal Regulations, title 42, section 493,
25.26promulgated in accordance with the Clinical Laboratory Improvement Act amendments
25.27of 1988, Public Law 100-578; or
25.28    (2) meet or exceed the Occupational Safety and Health Standards for Lead in
25.29General Industries, Code of Federal Regulations, section 1910.1025, and Occupational
25.30Safety and Health Standards for Lead in Construction, Code of Federal Regulations,
25.31section 1926.62; or
25.32    (3) meet or exceed the standards established by the commissioner under paragraph
25.33(c) for filter paper testing.
25.34    (b) A laboratory performing lead analysis of paint, soil, or dust must be a laboratory
25.35recognized by the United States Environmental Protection Agency under the Toxic
25.36Substances Control Act, United States Code, title 15, section 2685, paragraph (b).
26.1Analysis of samples of drinking water must be performed by a laboratory certified by
26.2the commissioner to analyze lead in water.
26.3    (c) The commissioner shall establish minimum standards for the use of filter paper
26.4tests in analyzing blood lead levels.

26.5    Sec. 22. Minnesota Statutes 2006, section 144.9504, subdivision 2, is amended to read:
26.6    Subd. 2. Lead risk assessment. (a) An assessing agency shall conduct a lead risk
26.7assessment of a residence according to the venous blood lead level, as determined by a
26.8venous blood draw or second filter paper test, and time frame set forth in clauses (1) to
26.9(4) for purposes of secondary prevention:
26.10    (1) within 48 hours of a child or pregnant female in the residence being identified to
26.11the agency as having a venous blood lead level equal to or greater than 60 45 micrograms
26.12of lead per deciliter of whole blood, as confirmed by a venous blood draw or second
26.13filter paper test;
26.14    (2) within five working days of a child or pregnant female in the residence being
26.15identified to the agency as having a venous blood lead level equal to or greater than 45 15
26.16micrograms of lead per deciliter of whole blood, as confirmed by a venous blood draw or
26.17second filter paper test;
26.18    (3) within ten working days of a child in the residence being identified to the agency
26.19as having a venous blood lead level equal to or greater than 15 ten micrograms of lead per
26.20deciliter of whole blood, as confirmed by a venous blood draw or second filter paper test; or
26.21    (4) within ten working days of a pregnant female in the residence being identified to
26.22the agency as having a venous blood lead level equal to or greater than ten ten micrograms
26.23of lead per deciliter of whole blood, as confirmed by a venous blood draw or second
26.24filter paper test.
26.25    (b) Within the limits of available local, state, and federal appropriations, an assessing
26.26agency may also conduct a lead risk assessment for children with any elevated blood
26.27lead level.
26.28    (c) In a building with two or more dwelling units, an assessing agency shall assess
26.29the individual unit in which the conditions of this section are met and shall inspect all
26.30common areas accessible to a child. If a child visits one or more other sites such as another
26.31residence, or a residential or commercial child care facility, playground, or school, the
26.32assessing agency shall also inspect the other sites. The assessing agency shall have one
26.33additional day added to the time frame set forth in this subdivision to complete the lead
26.34risk assessment for each additional site.
26.35    (d) Within the limits of appropriations, the assessing agency shall identify the
26.36known addresses for the previous 12 months of the child or pregnant female with venous
27.1blood lead levels of at least 15 ten micrograms per deciliter for the child or at least
27.2ten micrograms per deciliter for the pregnant female, as confirmed by a venous blood
27.3draw or second filter paper test; notify the property owners, landlords, and tenants at
27.4those addresses that an elevated blood lead level was found in a person who resided
27.5at the property; and give them primary prevention information. Within the limits of
27.6appropriations, the assessing agency may perform a risk assessment and issue corrective
27.7orders in the properties, if it is likely that the previous address contributed to the child's
27.8or pregnant female's blood lead level. The assessing agency shall provide the notice
27.9required by this subdivision without identifying the child or pregnant female with the
27.10elevated blood lead level. The assessing agency is not required to obtain the consent of
27.11the child's parent or guardian or the consent of the pregnant female for purposes of this
27.12subdivision. This information shall be classified as private data on individuals as defined
27.13under section 13.02, subdivision 12.
27.14    (e) The assessing agency shall conduct the lead risk assessment according to rules
27.15adopted by the commissioner under section 144.9508. An assessing agency shall have
27.16lead risk assessments performed by lead risk assessors licensed by the commissioner
27.17according to rules adopted under section 144.9508. If a property owner refuses to allow
27.18a lead risk assessment, the assessing agency shall begin legal proceedings to gain entry
27.19to the property and the time frame for conducting a lead risk assessment set forth in this
27.20subdivision no longer applies. A lead risk assessor or assessing agency may observe the
27.21performance of lead hazard reduction in progress and shall enforce the provisions of this
27.22section under section 144.9509. Deteriorated painted surfaces, bare soil, and dust must be
27.23tested with appropriate analytical equipment to determine the lead content, except that
27.24deteriorated painted surfaces or bare soil need not be tested if the property owner agrees to
27.25engage in lead hazard reduction on those surfaces. The lead content of drinking water
27.26must be measured if another probable source of lead exposure is not identified. Within a
27.27standard metropolitan statistical area, an assessing agency may order lead hazard reduction
27.28of bare soil without measuring the lead content of the bare soil if the property is in a
27.29census tract in which soil sampling has been performed according to rules established by
27.30the commissioner and at least 25 percent of the soil samples contain lead concentrations
27.31above the standard in section 144.9508.
27.32    (f) Each assessing agency shall establish an administrative appeal procedure which
27.33allows a property owner to contest the nature and conditions of any lead order issued by
27.34the assessing agency. Assessing agencies must consider appeals that propose lower cost
27.35methods that make the residence lead safe. The commissioner shall use the authority and
27.36appeal procedure granted under sections 144.989 to 144.993.
28.1    (g) Sections 144.9501 to 144.9509 neither authorize nor prohibit an assessing agency
28.2from charging a property owner for the cost of a lead risk assessment.

28.3    Sec. 23. Minnesota Statutes 2006, section 144.9507, is amended by adding a
28.4subdivision to read:
28.5    Subd. 6. Medical assistance. Medical assistance reimbursement for lead risk
28.6assessment services under section 256B.0625, subdivision 49, shall not be used to replace
28.7or decrease existing state or local funding for lead services and lead-related activities.

28.8    Sec. 24. Minnesota Statutes 2006, section 144.9512, is amended to read:
28.10    Subdivision 1. Definitions. (a) The definitions in section 144.9501 and in this
28.11subdivision apply to this section.
28.12    (b) "Eligible organization" means a lead contractor, city, board of health, community
28.13health department, community action agency as defined in section 256E.30, or community
28.14development corporation.
28.15    (c) "Commissioner" means the commissioner of health, or the commissioner of the
28.16Minnesota Housing Finance Agency as authorized by section 462A.05, subdivision 15c.
28.17    Subd. 2. Grants; administration. Within the limits of the available appropriation,
28.18the commissioner must develop a swab team services program which may shall make
28.19demonstration and training grants to eligible organizations a nonprofit organization
28.20currently operating the CLEARCorps lead hazard reduction project to train workers to
28.21provide swab team services and swab team services for residential property. Grants may
28.22be awarded to nonprofit organizations to provide technical assistance and training to
28.23ensure quality and consistency within the statewide program. Grants must be awarded to
28.24help ensure full-time employment to workers providing swab team services and must be
28.25awarded for a two-year period.
28.26    Grants awarded under this section must be made in consultation with the
28.27commissioner of the Housing Finance Agency and representatives of neighborhood
28.28groups from areas at high risk for toxic lead exposure, a labor organization, the lead
28.29coalition, community action agencies, and the legal aid society. The consulting team must
28.30review grant applications and recommend awards to eligible organizations that meet
28.31requirements for receiving a grant under this section.
28.32    Subd. 3. Applicants. (a) Interested eligible organizations may apply to the
28.33commissioner for grants under this section. Two or more eligible organizations may
28.34jointly apply for a grant. Priority shall be given to community action agencies in greater
28.35Minnesota and to either community action agencies or neighborhood based nonprofit
29.1organizations in cities of the first class. Of the total annual appropriation, 12.5 percent may
29.2be used for administrative purposes. The commissioner may deviate from this percentage
29.3if a grantee can justify the need for a larger administrative allowance. Of this amount,
29.4up to five percent may be used by the commissioner for state administrative purposes.
29.5Applications must provide information requested by the commissioner, including at least
29.6the information required to assess the factors listed in paragraph (d).
29.7    (b) The commissioner must consult with boards of health to provide swab team
29.8services for purposes of secondary prevention. The priority for swab teams created
29.9by grants to eligible organizations under this section must be work assigned by the
29.10commissioner of health, or by a board of health if so designated by the commissioner of
29.11health, to provide secondary prevention swab team services to fulfill the requirements
29.12of section 144.9504, subdivision 6, in response to a lead order. Swab teams assigned
29.13work under this section by the commissioner, that are not engaged daily in fulfilling the
29.14requirements of section 144.9504, subdivision 6, must deliver swab team services in
29.15response to elevated blood lead levels as defined in section 144.9501, subdivision 9,
29.16where lead orders were not issued, and for purposes of primary prevention in census
29.17tracts known to be in areas at high risk for toxic lead exposure as described in section
29.18144.9503, subdivision 2.
29.19    (c) Any additional money must be used for grants to establish swab teams for
29.20primary prevention under section 144.9503, in census tracts in areas at high risk for toxic
29.21lead exposure as determined under section 144.9503, subdivision 2.
29.22    (d) In evaluating grant applications, the commissioner must consider the following
29.24    (1) the use of lead contractors and lead workers for residential swab team services;
29.25    (2) the participation of neighborhood groups and individuals, as swab team workers,
29.26in areas at high risk for toxic lead exposure;
29.27    (3) plans for the provision of swab team services for primary and secondary
29.28prevention as required under subdivision 4;
29.29    (4) plans for supervision, training, career development, and postprogram placement
29.30of swab team members;
29.31    (5) plans for resident and property owner education on lead safety;
29.32    (6) plans for distributing cleaning supplies to area residents and educating residents
29.33and property owners on cleaning techniques;
29.34    (7) sources of other funding and cost estimates for training, lead inspections, swab
29.35team services, equipment, monitoring, testing, and administration;
29.36    (8) measures of program effectiveness;
30.1    (9) coordination of program activities with other federal, state, and local public
30.2health, job training, apprenticeship, and housing renovation programs including programs
30.3under sections 116L.86 to 116L.881; and
30.4    (10) prior experience in providing swab team services.
30.5    Subd. 4. Lead supervisor or certified firm Eligible grant activities. (a) Eligible
30.6organizations and lead supervisors or certified firms may participate in the swab team
30.7program. An eligible organization The nonprofit receiving a grant under this section
30.8must assure ensure that all participating lead supervisors or certified firms are licensed
30.9and that all swab team workers are certified by the Department of Health under section
30.10144.9505 . Eligible organizations and lead supervisors or certified firms may distinguish
30.11between interior and exterior services in assigning duties and The nonprofit organization
30.12may participate in the program by:
30.13    (1) providing on-the-job training for swab team workers;
30.14    (2) providing swab team services to meet the requirements of sections 144.9503,
30.15subdivision 4
, and 144.9504, subdivision 6;
30.16    (3) providing a removal and replacement component using skilled craft workers
30.17under subdivision 7 lead hazard reduction to meet the requirements of section 144.9501,
30.18subdivision 17;
30.19    (4) providing lead testing according to subdivision 8;
30.20    (5) (4) providing lead dust cleaning supplies cleanup equipment and materials, as
30.21described in section 144.9507 144.9503, subdivision 4, paragraph (c) 1, to residents; or
30.22    (6) (5) having a swab team worker instruct residents and property owners on
30.23appropriate lead control techniques, including the lead-safe directives developed by the
30.24commissioner of health.;
30.25    (6) conducting blood lead testing events including screening children and pregnant
30.26women according to Department of Health screening guidelines;
30.27    (7) performing case management services according to Department of Health case
30.28management guidelines; or
30.29    (8) conducting mandated risk assessments under Minnesota Statutes, section
30.30144.9504, subdivision 2.
30.31    (b) Participating lead supervisors or certified firms must:
30.32    (1) demonstrate proof of workers' compensation and general liability insurance
30.34    (2) be knowledgeable about lead abatement requirements established by the
30.35Department of Housing and Urban Development and the Occupational Safety and Health
31.1Administration and lead hazard reduction requirements and lead-safe directives of the
31.2commissioner of health;
31.3    (3) demonstrate experience with on-the-job training programs;
31.4    (4) demonstrate an ability to recruit employees from areas at high risk for toxic
31.5lead exposure; and
31.6    (5) demonstrate experience in working with low-income clients.
31.7    Subd. 5. Swab team workers. Each worker engaged in swab team services
31.8established under this section must have blood lead concentrations below 15 micrograms
31.9of lead per deciliter of whole blood as determined by a baseline blood lead screening.
31.10Any The nonprofit organization receiving a grant under this section is responsible for lead
31.11screening and must assure ensure that all swab team workers meet the standards established
31.12in this subdivision. Grantees The nonprofit organization must use appropriate workplace
31.13procedures including following the lead-safe directives developed by the commissioner of
31.14health to reduce risk of elevated blood lead levels. Grantees The nonprofit organization
31.15and participating contractors must report all employee blood lead levels that exceed 15
31.16micrograms of lead per deciliter of whole blood to the commissioner of health.
31.17    Subd. 6. On-the-job training component. (a) Programs established under this
31.18section must provide on-the-job training for swab team workers.
31.19    (b) Swab team workers must receive monetary compensation equal to the prevailing
31.20wage as defined in section 177.42, subdivision 6, for comparable jobs in the licensed
31.21contractor's principal business.
31.22    Subd. 7. Removal and replacement component. (a) Within the limits of the
31.23available appropriation and if a need is identified by a lead inspector, the commissioner
31.24may establish a component for removal and replacement of deteriorated paint in residential
31.25properties according to the following criteria:
31.26    (1) components within a residence must have both deteriorated lead-based paint and
31.27substrate damage beyond repair or rotting wooden framework to be eligible for removal
31.28and replacement;
31.29    (2) all removal and replacement must be done using least-cost methods and
31.30following lead-safe directives;
31.31    (3) whenever windows and doors or other components covered with deteriorated
31.32lead-based paint have sound substrate or are not rotting, those components should be
31.33repaired, sent out for stripping, planed down to remove deteriorated lead-based paint, or
31.34covered with protective guards instead of being replaced, provided that such an activity is
31.35the least-cost method of providing the swab team service;
32.1    (4) removal and replacement or repair must be done by lead contractors using skilled
32.2craft workers or trained swab team members; and
32.3    (5) all craft work that requires a state license must be supervised by a person with
32.4a state license in the craft work being supervised. The grant recipient may contract for
32.5this supervision.
32.6    (b) The program design must:
32.7    (1) identify the need for on-the-job training of swab team workers to be removal and
32.8replacement workers; and
32.9    (2) describe plans to involve appropriate groups in designing methods to meet the
32.10need for training swab team workers.
32.11    Subd. 8. Testing and evaluation. (a) Testing of the environment is not necessary
32.12by swab teams whose work is assigned by the commissioner of health or a designated
32.13board of health under section 144.9504. The commissioner of health or designated board
32.14of health must share the analytical testing data collected on each residence for purposes
32.15of secondary prevention under section 144.9504 with the swab team workers in order to
32.16provide constructive feedback on their work and to the commissioner for the purposes
32.17set forth in paragraph (c).
32.18    (b) For purposes of primary prevention evaluation, the following samples must be
32.19collected: pretesting and posttesting of one noncarpeted floor dust lead sample and a
32.20notation of the extent and location of bare soil and of deteriorated lead-based paint. The
32.21analytical testing data collected on each residence for purposes of primary prevention
32.22under section 144.9503 must be shared with the swab team workers in order to provide
32.23constructive feedback on their work and to the commissioner for the purposes set forth in
32.24paragraph (c).
32.25    (c) The commissioner of health must establish a program to collect appropriate data
32.26as required under paragraphs (a) and (b), in order to conduct an ongoing evaluation of
32.27swab team services for primary and secondary prevention. Within the limits of available
32.28appropriations, the commissioner of health must conduct on up to 1,000 residences which
32.29have received primary or secondary prevention swab team services, a postremediation
32.30evaluation, on at least a quarterly basis for a period of at least two years for each residence.
32.31The evaluation must note the condition of the paint within the residence, the extent of bare
32.32soil on the grounds, and collect and analyze one noncarpeted floor dust lead sample.
32.33The data collected must be evaluated to determine the efficacy of providing swab team
32.34services as a method of reducing lead exposure in young children. In evaluating this data,
32.35the commissioner of health must consider city size, community location, historic traffic
32.36flow, soil lead level of the property by area or census tract, distance to industrial point
33.1sources that emit lead, season of the year, age of the housing, age and number of children
33.2living at the residence, the presence of pets that move in and out of the residence, and
33.3other relevant factors as the commissioner of health may determine.
33.4    Subd. 9. Program benefits. As a condition of providing swab team services under
33.5this section, an the nonprofit organization may require a property owner to not increase
33.6rents on a property solely as a result of a substantial improvement made with public
33.7funds under the programs in this section.
33.8    Subd. 10. Requirements of organizations receiving grants the nonprofit
33.9organization. An eligible The nonprofit organization that is awarded a training and
33.10demonstration grant under this section must prepare and submit a quarterly progress report
33.11to the commissioner beginning three months after receipt of the grant.

33.14    Subdivision 1. Definitions. (a) "Child" means a person 18 years of age or younger.
33.15    (b) "False positive rate" means the proportion of infants identified as having a
33.16significant hearing loss by the screening process who are ultimately found to not have a
33.17significant hearing loss.
33.18    (c) "False negative rate" means the proportion of infants not identified as having
33.19a significant hearing loss by the screening process who are ultimately found to have a
33.20significant hearing loss.
33.21    (d) "Hearing screening test" means automated auditory brain stem response,
33.22otoacoustic emissions, or another appropriate screening test approved by the Department
33.23of Health.
33.24    (e) "Hospital" means a birthing health care facility or birthing center licensed in
33.25this state that provides obstetrical services.
33.26    (f) "Infant" means a child who is not a newborn and has not attained the age of
33.27one year.
33.28    (g) "Newborn" means an infant 28 days old or younger.
33.29    (h) "Parent" means a natural parent, stepparent, adoptive parent, guardian, or
33.30custodian of a newborn or infant.
33.31    Subd. 2. Newborn Hearing Screening Advisory Committee. (a) The
33.32commissioner of health shall appoint a Newborn Hearing Screening Advisory Committee
33.33to advise and assist the Department of Health and the Department of Education in:
34.1    (1) developing protocols and timelines for screening, rescreening, and diagnostic
34.2audiological assessment and early medical, audiological, and educational intervention
34.3services for children who are deaf or hard-of-hearing;
34.4    (2) designing protocols for tracking children from birth through age three that may
34.5have passed newborn screening but are at risk for delayed or late onset of permanent
34.6hearing loss;
34.7    (3) designing a technical assistance program to support facilities implementing the
34.8screening program and facilities conducting rescreening and diagnostic audiological
34.10    (4) designing implementation and evaluation of a system of follow-up and tracking;
34.12    (5) evaluating program outcomes to increase effectiveness and efficiency and ensure
34.13culturally appropriate services for children with a confirmed hearing loss and their families.
34.14    (b) Membership of the committee shall include at least one member from each of the
34.15following groups with no less than two of the members being deaf or hard-of-hearing:
34.16    (1) a representative from a consumer organization representing culturally deaf
34.18    (2) a parent with a child with hearing loss representing a parent organization;
34.19    (3) a consumer from an organization representing oral communication options;
34.20    (4) a consumer from an organization representing cued speech communication
34.22    (5) an audiologist who has experience in evaluation and intervention of infants
34.23and young children;
34.24    (6) a speech-language pathologist who has experience in evaluation and intervention
34.25of infants and young children;
34.26    (7) two primary care providers who have experience in the care of infants and young
34.27children, one of which shall be a pediatrician;
34.28    (8) a representative from the early hearing detection intervention teams;
34.29    (9) a representative from the Department of Education resource center for the deaf
34.30and hard-of-hearing or their designee;
34.31    (10) a representative of the Minnesota Commission Serving Deaf and Hard of
34.32Hearing People;
34.33    (11) a representative from the Department of Human Services Deaf and Hard of
34.34Hearing Services Division;
34.35    (12) one or more of the Part C coordinators from the Department of Education, the
34.36Department of Health, or the Department of Human Services or their designee;
35.1    (13) the Department of Health early hearing detection and intervention coordinator;
35.2    (14) two birth hospital representatives from one rural and one urban hospital;
35.3    (15) a pediatric geneticist;
35.4    (16) an otolaryngologist;
35.5    (17) a representative from the Newborn Screening Advisory Committee under
35.6this subdivision; and
35.7    (18) a representative of the Department of Education regional low-incidence
35.9    The Department of Health member shall chair the first meeting of the committee.
35.10At the first meeting, the committee shall elect a chairperson from its membership. The
35.11committee shall meet at the call of the chairperson, at least four times a year. The
35.12committee shall adopt written bylaws to govern its activities. The Department of Health
35.13shall provide technical and administrative support services as required by the committee.
35.14These services shall include technical support from individuals qualified to administer
35.15infant hearing screening, rescreening, and diagnostic audiological assessments.
35.16    Members of the committee shall receive no compensation for their service, but
35.17shall be reimbursed for expenses incurred as a result of their duties as members of the
35.19    Subd. 3. Newborn and infant hearing screening programs. All hospitals shall
35.20establish a Universal Newborn Hearing and Infant Screening (UNHS) program. Each
35.21UNHS program shall:
35.22    (1) in advance of any hearing screening testing, provide to the newborn's or infant's
35.23parents information concerning the nature of the screening procedure, applicable costs of
35.24the screening procedure, the potential risks and effects of hearing loss, and the benefits of
35.25early detection and intervention;
35.26    (2) comply with parental consent under section 144.125, subdivision 3;
35.27    (3) develop policies and procedures for screening and rescreening based on
35.28Department of Health recommendations;
35.29    (4) provide appropriate training and monitoring of individuals responsible for
35.30performing hearing screening tests as recommended by the Department of Health;
35.31    (5) test the newborn's hearing prior to discharge, or, if the newborn is expected to
35.32remain in the hospital for a prolonged period, testing shall be performed prior to three
35.33months of age, or when medically feasible;
35.34    (6) develop and implement procedures for documenting the results of all hearing
35.35screening tests;
36.1    (7) inform the baby's parents or parent, primary care physician, and the Department
36.2of Health according to recommendations of the Department of Health of the results of the
36.3hearing screening test or rescreening if conducted, or if the newborn or infant was not
36.4successfully tested. The hospital that discharges the baby to home is responsible for
36.5the screening; and
36.6    (8) collect performance data specified by the Department of Health.
36.7    Subd. 4. Notification and information. (a) Notification to the parents, primary
36.8care provider, and Department of Health shall occur prior to discharge or no later than ten
36.9days following the date of testing. Notification shall include information recommended by
36.10the Department of Health.
36.11    (b) A physician, nurse, midwife, or other health professional attending a birth outside
36.12a hospital or institution shall provide information, orally and in writing, as established by
36.13the Department of Health, to parents regarding places where the parents may have their
36.14infants' hearing screened and the importance of such screening.
36.15    (c) The professional conducting the diagnostic procedure to confirm the hearing loss
36.16must report the results to the parents, primary care provider, and Department of Health
36.17according to the Department of Health recommendations.
36.18    Subd. 5. Oversight responsibility. The Department of Health shall exercise
36.19oversight responsibility for UNHS programs, including establishing a performance data
36.20set and reviewing performance data collected by each hospital.
36.21    Subd. 6. Civil and criminal immunity and penalties. (a) No physician or hospital
36.22shall be civilly or criminally liable for failure to conduct hearing screening testing.
36.23    (b) No physician, midwife, nurse, other health professional, or hospital acting in
36.24compliance with this section shall be civilly or criminally liable for any acts conforming
36.25with this section, including furnishing information required according to this section.
36.26    Subd. 7. Laboratory service fees. The commissioner shall charge laboratory
36.27service fees according to section 16A.1285 so that the total of fees collected will
36.28approximate the costs of implementing and maintaining a system to follow up infants,
36.29provide technical assistance, a tracking system, data management, and evaluation.
36.30EFFECTIVE DATE.This section is effective the day following final enactment.

36.31    Sec. 26. [144.967] ARSENIC HEALTH RISK STANDARD.
36.32    Subdivision 1. Arsenic health risk standard established. The commissioner of
36.33health in cooperation with the commissioners of agriculture and the Pollution Control
36.34Agency responsible for monitoring land and water cleanup and soil contamination
37.1information shall determine a health risk standard for human exposure to arsenic. The
37.2commissioner of health shall ensure that the established arsenic health risk standard is
37.3included in all information provided to the public.
37.4    Subd. 2. Information. The commissioner of health, in consultation with the
37.5commissioners of agriculture and the Pollution Control Agency with jurisdiction over
37.6soil and water contamination, shall establish a central information source available to
37.7the public to provide accurate information on arsenic soil and water contamination in
37.8residential areas.
37.9    Subd. 3. Testing for arsenic. (a) The commissioner of health shall ensure access
37.10to medical testing for arsenical pesticide exposure to persons living within one mile of
37.11the CMC Heartland Lite Yard Superfund site who are not covered by health insurance or
37.12medical assistance.
37.13    (b) Through an agreement with the United States Environmental Protection Agency,
37.14the commissioner shall ensure soil testing is available to households within one mile of the
37.15CMC Heartland Lite Yard Superfund site at no cost to the residents.
37.16    Subd. 4. Evaluation. The commissioner of health shall evaluate the cumulative
37.17health impact burdens of environmental toxins in the residential communities impacted by
37.18arsenic-contaminated soil from the CMC Heartland Lite Yard Superfund site. The first
37.19priority shall be to evaluate health burdens to those communities experiencing health
37.20disparities as documented by the Minority and Multicultural Health Division of the
37.21Minnesota Department of Health.

37.22    Sec. 27. [144.995] DEFINITIONS.
37.23    (a) For purposes of sections 144.995 to 144.998, the terms in this section have
37.24the meanings given.
37.25    (b) "Advisory panel" means the Environmental Health Tracking and Biomonitoring
37.26Advisory Panel established under section 144.998.
37.27    (c) "Biomonitoring" means the process by which chemicals and their metabolites are
37.28identified and measured within a biospecimen.
37.29    (d) "Biospecimen" means a sample of human fluid, serum, or tissue that is reasonably
37.30available as a medium to measure the presence and concentration of chemicals or their
37.31metabolites in a human body.
37.32    (e) "Commissioner" means the commissioner of the Department of Health.
37.33    (f) "Community" means geographically or nongeographically-based populations
37.34that may participate in the biomonitoring program. A "nongeographical community"
37.35includes, but is not limited to, populations that may share a common chemical exposure
38.1through similar occupations, populations experiencing a common health outcome that
38.2may be linked to chemical exposures, or populations that may experience similar chemical
38.3exposures because of comparable consumption, lifestyle, product use, or subpopulations
38.4that share ethnicity, age, or gender.
38.5    (g) "Department" means the Department of Health.
38.6    (h) "Designated chemicals" means those chemicals that are known to, or strongly
38.7suspected of, adversely impacting human health or development, based upon scientific,
38.8peer-reviewed animal, human, or in vitro studies, and baseline human exposure data,
38.9and consists of chemical families or metabolites that are included in the federal Centers
38.10for Disease Control and Prevention studies that are known collectively as the National
38.11Reports on Human Exposure to Environmental Chemicals program and any substances
38.12specified under section 144.998, subdivision 3, clause (6).
38.13    (i) " Environmental hazard" means a chemical, metal, or other substance for which
38.14scientific, peer-reviewed studies of humans, animals, or cells have demonstrated that the
38.15chemical is known or reasonably anticipated to adversely impact human health.
38.16    (j) "Environmental health tracking" means collection, integration, analysis, and
38.17dissemination of data on human exposures to chemicals in the environment and on
38.18diseases potentially caused or aggravated by those chemicals.

38.19    Sec. 28. [144.996] ENVIRONMENTAL HEALTH TRACKING;
38.21    Subdivision 1. Environmental health tracking. In cooperation with the
38.22commissioner of the Pollution Control Agency, the commissioner shall establish an
38.23environmental health tracking program to:
38.24    (1) coordinate data collection activities with the Pollution Control Agency,
38.25Department of Agriculture, University of Minnesota, and any other relevant state agency
38.26and work to promote the sharing of and access to health and environmental databases
38.27in order to develop an environmental health tracking system for Minnesota, consistent
38.28with applicable data practices laws;
38.29    (2) facilitate the dissemination of public health tracking data to the public and
38.30researchers in accessible format and provide technical assistance on interpreting the data;
38.31    (3) develop written data sharing agreements with the Minnesota Pollution Control
38.32Agency, Department of Agriculture, and other relevant state agencies and organizations,
38.33and develop additional procedures as needed to protect individual privacy;
38.34    (4) develop a strategic plan that includes a mission statement, the identification of
38.35core priorities for research and epidemiologic surveillance, the identification of internal
38.36and external stakeholders, and a work plan describing future program development;
39.1    (5) organize, analyze, and interpret available data, in order to:
39.2    (i) characterize statewide and localized trends and geographic patterns of prevalence
39.3and incidence of chronic diseases, including, but not limited to, cancer, respiratory
39.4diseases, reproductive problems, birth defects, neurologic diseases, and developmental
39.6    (ii) recommend to the commissioner methods to improve data collection on
39.7statewide population rates of chronic diseases and the occurrence of environmental
39.8hazards and exposures;
39.9    (iii) characterize statewide and localized trends and geographic patterns in the
39.10occurrence of environmental hazards and exposures;
39.11    (iv) assess the level of correlation with disease rate data and indicators of exposure
39.12such as biomonitoring data, and other health and environmental data;
39.13    (v) incorporate newly collected and existing health tracking and biomonitoring
39.14data into efforts to identify communities with elevated rates of chronic disease, higher
39.15likelihood of exposure to environmental pollutants, or both;
39.16    (vi) analyze occurrence of environmental hazards, exposures, and diseases with
39.17relation to socioeconomic status, race, and ethnicity;
39.18    (vii) develop and implement targeted plans to conduct more intensive health tracking
39.19and biomonitoring among communities;
39.20    (viii) work with the Pollution Control Agency, the Department of Agriculture, and
39.21other relevant state agency personnel and organizations to develop, implement, and
39.22evaluate preventive measures to reduce elevated rates of diseases and exposures identified
39.23through activities performed under sections 144.995 to 144.998; and
39.24    (ix) provide baseline data and present descriptive information relevant to policy
39.25formation that are consistent with existing goals of the department; and
39.26    (6) submit a biennial report to the legislature by January 15, beginning January
39.2715, 2009, on the status of environmental health tracking activities and related research
39.28programs, and making recommendations regarding the continuation and improvement of
39.29the programs.
39.30    Subd. 2. Biomonitoring. The commissioner shall:
39.31    (1) conduct biomonitoring of communities on a voluntary basis by collecting and
39.32analyzing biospecimens, as appropriate, to assess environmental exposures to designated
39.34    (2) conduct biomonitoring of pregnant women and minors on a voluntary basis,
39.35when scientifically appropriate;
40.1    (3) communicate findings to the public, and plan ensuing stages of biomonitoring
40.2and disease tracking work to further develop and refine the integrated analysis;
40.3    (4) share analytical results with the advisory panel and work with the panel
40.4to interpret results, communicate findings to the public, and plan ensuing stages of
40.5biomonitoring work; and
40.6    (5) submit a biennial report to the legislature by January 15, beginning January
40.715, 2009, on the status of the biomonitoring program and any recommendations for
40.9    Subd. 3. Health data. Data collected under the biomonitoring program are health
40.10data under section 13.3805.

40.11    Sec. 29. [144.997] BIOMONITORING PILOT PROGRAM.
40.12    Subdivision 1. Pilot program. With advice from the advisory panel, the
40.13commissioner shall develop a biomonitoring pilot program. The program shall collect
40.14one biospecimen from each of the voluntary participants. The biospecimen selected must
40.15be the biospecimen that most accurately represents body concentration of the chemical
40.16of interest. Each biospecimen from the voluntary participants must be analyzed for one
40.17type or class of related chemicals or metals, based on recommendations from the advisory
40.18panel. The panel shall determine the chemical or class of chemicals that community
40.19members were most likely exposed to. The program shall collect and assess biospecimens
40.20in accordance with the following:
40.21    (1) 30 voluntary participants from each of three communities that the advisory panel
40.22identifies as likely to have been exposed to a designated chemical;
40.23    (2) 100 voluntary participants from each of two communities: (i) that the advisory
40.24panel identifies as likely to have been exposed to arsenic and (ii) that the advisory panel
40.25identifies as likely to have been exposed to mercury; and
40.26    (3) 100 voluntary participants from each of two communities that the advisory panel
40.27identifies as likely to have been exposed to perfluorinated chemicals.
40.28    Subd. 2. Base program. Following the conclusion of the pilot program and within
40.29the appropriations available, the program shall:
40.30    (1) collect and assess biospecimens from at least as many voluntary participants and
40.31communities as identified in subdivision 1, clause (1); and
40.32    (2) work with the advisory panel to assess the usefulness of continuing biomonitoring
40.33among members of communities assessed during the initial phase of the program,
40.34and to identify other communities and other designated chemicals to be assessed via
41.1    Subd. 3. Participation. (a) Participation in the biomonitoring program by providing
41.2biospecimens is voluntary and requires written, informed consent. Minors may participate
41.3in the program if a written consent is signed by the minor's parent or legal guardian.
41.4The written consent must include the information required to be provided under this
41.5subdivision to all voluntary participants.
41.6    (b) All participants shall be evaluated for the presence of the designated chemical
41.7of interest as a component of the biomonitoring process. Participants shall be provided
41.8with information and fact sheets about the program's activities and its findings.
41.9Individual participants shall, if requested, receive their complete results. Any results
41.10provided to participants shall be subject to the Department of Health Institutional
41.11Review Board protocols and guidelines. When either physiological or chemical data
41.12obtained from a participant indicate a significant known health risk, program staff
41.13experienced in communicating biomonitoring results shall consult with the individual
41.14and recommend follow-up steps, as appropriate. Program administrators shall receive
41.15training in administering the program in an ethical, culturally sensitive, participatory,
41.16and community-based manner.
41.17    Subd. 4. Program guidelines. (a) The commissioner, in consultation with the
41.18advisory panel, shall develop:
41.19    (1) protocols or program guidelines that address the science and practice of
41.20biomonitoring to be utilized and procedures for changing those protocols to incorporate
41.21new and more accurate or efficient technologies as they become available. The protocols
41.22shall be developed utilizing a peer-review process in a manner that is participatory and
41.23community-based in design, implementation, and evaluation;
41.24    (2) guidelines for ensuring the privacy of information; informed consent; follow-up
41.25counseling and support; and communicating findings to participants, communities, and
41.26the general public. The informed consent used for the program must meet the informed
41.27consent protocols developed by the National Institutes of Health;
41.28    (3) educational and outreach materials that are culturally appropriate for
41.29dissemination to program participants and communities. Priority shall be given to the
41.30development of materials specifically designed to ensure that parents are informed about
41.31all of the benefits of breastfeeding so that the program does not result in an unjustified fear
41.32of toxins in breast milk, which might inadvertently lead parents to avoid breastfeeding.
41.33The materials shall communicate relevant scientific findings; data on the accumulation
41.34of pollutants to community health; and the required responses by local, state, and other
41.35governmental entities in regulating toxicant exposures;
42.1    (4) a training program that is culturally sensitive specifically for health care
42.2providers, health educators, and other program administrators;
42.3    (5) a designation process for state and private laboratories that are qualified to
42.4analyze biospecimens and report the findings; and
42.5    (6) a method for informing affected communities and local governments representing
42.6those communities concerning biomonitoring activities and for receiving comments from
42.7citizens concerning those activities.
42.8    (b) The commissioner may enter into contractual agreements with health clinics,
42.9community-based organizations, or experts in a particular field to perform any of the
42.10activities described under this section.

42.13    Subdivision 1. Creation. The commissioner shall establish the Environmental
42.14Health Tracking and Biomonitoring Advisory Panel. The commissioner shall appoint,
42.15from the panel's membership, a chair. The panel shall meet as often as it deems necessary
42.16but, at a minimum, on a quarterly basis. Members of the panel shall serve without
42.17compensation but shall be reimbursed for travel and other necessary expenses incurred
42.18through performance of their duties. Members appointed under this subdivision are
42.19appointed for a three-year term and may be reappointed.
42.20    Subd. 2. Members. The commissioner shall appoint eight members who have
42.21backgrounds or training in designing, implementing, and interpreting health tracking and
42.22biomonitoring studies or in related fields of science, including epidemiology, biostatistics,
42.23environmental health, laboratory sciences, occupational health, industrial hygiene,
42.24toxicology, and public health, including:
42.25    (1) two scientists who represent nongovernmental organizations with a focus on
42.26environmental health, environmental justice, children's health, or on specific chronic
42.27diseases; and
42.28    (2) one scientist who is a representative of the University of Minnesota.
42.29    In addition, the commissioner shall appoint one member representing each of the
42.30following departments or divisions: the department's health promotion and chronic disease
42.31division, the Pollution Control Agency, and the Department of Agriculture.
42.32    Subd. 3. Duties. The advisory panel shall make recommendations to the
42.33commissioner and the legislature on:
42.34    (1) priorities for health tracking;
43.1    (2) priorities for biomonitoring that are based on sound science and practice, and
43.2that will advance the state of public health in Minnesota;
43.3    (3) specific chronic diseases to study under the environmental health tracking system;
43.4    (4) specific environmental pollutant exposures to study under the environmental
43.5health tracking system;
43.6    (5) specific communities and geographic areas on which to focus environmental
43.7health tracking and biomonitoring efforts;
43.8    (6) specific chemicals and metals to study under the biomonitoring program that
43.9meet the following criteria:
43.10    (i) the degree of potential exposure to the public or specific subgroups, including,
43.11but not limited to, occupational;
43.12    (ii) the likelihood of a chemical being a carcinogen or toxicant based on
43.13peer-reviewed health data, the chemical structure, or the toxicology of chemically related
43.15    (iii) the limits of laboratory detection for the chemical, including the ability to detect
43.16the chemical at low enough levels that could be expected in the general population;
43.17    (iv) exposure or potential exposure to the public or specific subgroups;
43.18    (v) the known or suspected health effects resulting from the same level of exposure
43.19based on peer-reviewed scientific studies;
43.20    (vi) the need to assess the efficacy of public health actions to reduce exposure to a
43.22    (vii) the availability of a biomonitoring analytical method with adequate accuracy,
43.23precision, sensitivity, specificity, and speed;
43.24    (viii) the availability of adequate biospecimen samples; and
43.25    (ix) other criteria that the panel may agree to; and
43.26    (7) other aspects of the design, implementation, and evaluation of the environmental
43.27health tracking and biomonitoring system, including, but not limited to:
43.28    (i) identifying possible community partners and sources of additional public or
43.29private funding;
43.30    (ii) developing outreach and educational methods and materials; and
43.31    (iii) disseminating environmental health tracking and biomonitoring findings to
43.32the public.
43.33    Subd. 4. Liability. No member of the panel shall be held civilly or criminally liable
43.34for an act or omission by that person if the act or omission was in good faith and within
43.35the scope of the member's responsibilities under sections 144.995 to 144.998.

43.36    Sec. 31. Minnesota Statutes 2006, section 145A.17, is amended to read:
44.2    Subdivision 1. Establishment; goals. The commissioner shall establish a program
44.3to fund family home visiting programs designed to foster a healthy beginning for children
44.4in families at or below 200 percent of the federal poverty guidelines beginnings, improve
44.5pregnancy outcomes, promote school readiness, prevent child abuse and neglect, reduce
44.6juvenile delinquency, promote positive parenting and resiliency in children, and promote
44.7family health and economic self-sufficiency for children and families. The commissioner
44.8shall promote partnerships, collaboration, and multidisciplinary visiting done by teams of
44.9professionals and paraprofessionals from the fields of public health nursing, social work,
44.10and early childhood education. A program funded under this section must serve families
44.11at or below 200 percent of the federal poverty guidelines, and other families determined
44.12to be at risk, including but not limited to being at risk for child abuse, child neglect, or
44.13juvenile delinquency. Programs must give priority for services to families considered to
44.14be in need of services, including but not limited to begin prenatally whenever possible and
44.15must be targeted to families with:
44.16    (1) adolescent parents;
44.17    (2) a history of alcohol or other drug abuse;
44.18    (3) a history of child abuse, domestic abuse, or other types of violence;
44.19    (4) a history of domestic abuse, rape, or other forms of victimization;
44.20    (5) reduced cognitive functioning;
44.21    (6) a lack of knowledge of child growth and development stages;
44.22    (7) low resiliency to adversities and environmental stresses; or
44.23    (8) insufficient financial resources to meet family needs;
44.24    (9) a history of homelessness;
44.25    (10) a risk of long-term welfare dependence or family instability due to employment
44.26barriers; or
44.27    (11) other risk factors as determined by the commissioner.
44.28    Subd. 3. Requirements for programs; process. (a) Before a community health
44.29board or tribal government may receive an allocation under subdivision 2, a community
44.30health board or tribal government must submit a proposal to the commissioner that
44.31includes identification, based on a community assessment, of the populations at or below
44.32200 percent of the federal poverty guidelines that will be served and the other populations
44.33that will be served. Each program that receives funds must Community health boards
44.34and tribal governments that receive funding under this section must submit a plan to
44.35the commissioner describing a multidisciplinary approach to targeted home visiting for
45.1families. The plan must be submitted on forms provided by the commissioner. At a
45.2minimum, the plan must include the following:
45.3    (1) a description of outreach strategies to families prenatally or at birth;
45.4    (2) provisions for the seamless delivery of health, safety, and early learning services;
45.5    (3) methods to promote continuity of services when families move within the state;
45.6    (4) a description of the community demographics;
45.7    (5) a plan for meeting outcome measures; and
45.8    (6) a proposed work plan that includes:
45.9    (i) coordination to ensure nonduplication of services for children and families;
45.10    (ii) a description of the strategies to ensure that children and families at greatest risk
45.11receive appropriate services; and
45.12    (iii) collaboration with multidisciplinary partners including public health,
45.13ECFE, Head Start, community health workers, social workers, community home
45.14visiting programs, school districts, and other relevant partners. Letters of intent from
45.15multidisciplinary partners must be submitted with the plan.
45.16    (b) Each program that receives funds must accomplish the following program
45.18    (1) use either a broad community-based or selective community-based strategy to
45.19provide preventive and early intervention home visiting services;
45.20    (2) offer a home visit by a trained home visitor. If a home visit is accepted, the first
45.21home visit must occur prenatally or as soon after birth as possible and must include a
45.22public health nursing assessment by a public health nurse;
45.23    (3) offer, at a minimum, information on infant care, child growth and development,
45.24positive parenting, preventing diseases, preventing exposure to environmental hazards,
45.25and support services available in the community;
45.26    (4) provide information on and referrals to health care services, if needed, including
45.27information on and assistance in applying for health care coverage for which the child or
45.28family may be eligible; and provide information on preventive services, developmental
45.29assessments, and the availability of public assistance programs as appropriate;
45.30    (5) provide youth development programs when appropriate;
45.31    (6) recruit home visitors who will represent, to the extent possible, the races,
45.32cultures, and languages spoken by families that may be served;
45.33    (7) train and supervise home visitors in accordance with the requirements established
45.34under subdivision 4;
45.35    (8) maximize resources and minimize duplication by coordinating activities or
45.36contracting with local social and human services organizations, education organizations,
46.1and other appropriate governmental entities and community-based organizations and
46.2agencies; and
46.3    (9) utilize appropriate racial and ethnic approaches to providing home visiting
46.4services; and
46.5    (10) connect eligible families, as needed, to additional resources available in the
46.6community, including, but not limited to, early care and education programs, health or
46.7mental health services, family literacy programs, employment agencies, social services,
46.8and child care resources and referral agencies.
46.9    (c) When available, programs that receive funds under this section must offer or
46.10provide the family with a referral to center-based or group meetings that meet at least
46.11once per month for those families identified with additional needs. The meetings must
46.12focus on further enhancing the information, activities, and skill-building addressed during
46.13home visitation; offering opportunities for parents to meet with and support each other;
46.14and offering infants and toddlers a safe, nurturing, and stimulating environment for
46.15socialization and supervised play with qualified teachers.
46.16    (b) (d) Funds available under this section shall not be used for medical services. The
46.17commissioner shall establish an administrative cost limit for recipients of funds. The
46.18outcome measures established under subdivision 6 must be specified to recipients of
46.19funds at the time the funds are distributed.
46.20    (c) (e) Data collected on individuals served by the home visiting programs must
46.21remain confidential and must not be disclosed by providers of home visiting services
46.22without a specific informed written consent that identifies disclosures to be made.
46.23Upon request, agencies providing home visiting services must provide recipients with
46.24information on disclosures, including the names of entities and individuals receiving the
46.25information and the general purpose of the disclosure. Prospective and current recipients
46.26of home visiting services must be told and informed in writing that written consent for
46.27disclosure of data is not required for access to home visiting services.
46.28    Subd. 4. Training. The commissioner shall establish training requirements for
46.29home visitors and minimum requirements for supervision by a public health nurse. The
46.30requirements for nurses must be consistent with chapter 148. The commissioner must
46.31provide training for home visitors. Training must include child development, positive
46.32parenting techniques, screening and referrals for child abuse and neglect, and diverse
46.33cultural practices in child rearing and family systems the following:
46.34    (1) effective relationships for engaging and retaining families and ensuring family
46.35health, safety, and early learning;
47.1    (2) effective methods of implementing parent education, conducting home visiting,
47.2and promoting quality early childhood development;
47.3    (3) early childhood development from birth to age five;
47.4    (4) diverse cultural practices in child rearing and family systems;
47.5    (5) recruiting, supervising, and retaining qualified staff;
47.6    (6) increasing services for underserved populations; and
47.7    (7) relevant issues related to child welfare and protective services, with information
47.8provided being consistent with state child welfare agency training.
47.9    Subd. 5. Technical assistance. The commissioner shall provide administrative
47.10and technical assistance to each program, including assistance in data collection and
47.11other activities related to conducting short- and long-term evaluations of the programs
47.12as required under subdivision 7. The commissioner may request research and evaluation
47.13support from the University of Minnesota.
47.14    Subd. 6. Outcome and performance measures. The commissioner shall establish
47.15outcomes measures to determine the impact of family home visiting programs funded
47.16under this section on the following areas:
47.17    (1) appropriate utilization of preventive health care;
47.18    (2) rates of substantiated child abuse and neglect;
47.19    (3) rates of unintentional child injuries;
47.20    (4) rates of children who are screened and who pass early childhood screening; and
47.21    (5) rates of children accessing early care and educational services;
47.22    (6) program retention rates;
47.23    (7) number of home visits provided compared to the number of home visits planned;
47.24    (8) participant satisfaction;
47.25    (9) rates of at-risk populations reached; and
47.26    (10) any additional qualitative goals and quantitative measures established by the
47.28    Subd. 7. Evaluation. Using the qualitative goals and quantitative outcome and
47.29performance measures established under subdivisions 1 and 6, the commissioner shall
47.30conduct ongoing evaluations of the programs funded under this section. Community
47.31health boards and tribal governments shall cooperate with the commissioner in the
47.32evaluations and shall provide the commissioner with the information necessary to conduct
47.33the evaluations. As part of the ongoing evaluations, the commissioner shall rate the impact
47.34of the programs on the outcome measures listed in subdivision 6, and shall periodically
47.35determine whether home visiting programs are the best way to achieve the qualitative
48.1goals established under subdivisions 1 and 6. If the commissioner determines that home
48.2visiting programs are not the best way to achieve these goals, the commissioner shall
48.3provide the legislature with alternative methods for achieving them.
48.4    Subd. 8. Report. By January 15, 2002, and January 15 of each even-numbered
48.5year thereafter, the commissioner shall submit a report to the legislature on the family
48.6home visiting programs funded under this section and on the results of the evaluations
48.7conducted under subdivision 7.
48.8    Subd. 9. No supplanting of existing funds. Funding available under this section
48.9may be used only to supplement, not to replace, nonstate funds being used for home
48.10visiting services as of July 1, 2001.

48.11    Sec. 32. Minnesota Statutes 2006, section 156.001, is amended by adding a subdivision
48.12to read:
48.13    Subd. 10a. Program for the Assessment of Veterinary Education Equivalence;
48.14PAVE certificate. A "Program for the Assessment of Veterinary Education Equivalence"
48.15or "PAVE" certificate is issued by the American Association of Veterinary State Boards,
48.16indicating that the holder has demonstrated knowledge and skill equivalent to that
48.17possessed by a graduate of an accredited or approved college of veterinary medicine.

48.18    Sec. 33. [156.015] FEES.
48.19    Subdivision 1. Verification of licensure. The board may charge a fee of $25 per
48.20license verification to a licensee for verification of licensure status provided to other
48.21veterinary licensing boards.
48.22    Subd. 2. Continuing education review. The board may charge a fee of $50 per
48.23submission to a sponsor for review and approval of individual continuing education
48.24seminars, courses, wet labs, and lectures. This fee does not apply to continuing education
48.25sponsors that already meet the criteria for preapproval under Minnesota Rules, part
48.269100.1000, subpart 3, item A.

48.27    Sec. 34. Minnesota Statutes 2006, section 156.02, subdivision 1, is amended to read:
48.28    Subdivision 1. License application. Application for a license to practice veterinary
48.29medicine in this state shall be made in writing to the Board of Veterinary Medicine upon a
48.30form furnished by the board, accompanied by satisfactory evidence that the applicant is at
48.31least 18 years of age, is of good moral character, and has one of the following:
48.32    (1) a diploma conferring the degree of doctor of veterinary medicine, or an
48.33equivalent degree, from an accredited or approved college of veterinary medicine;
48.34    (2) an ECFVG or PAVE certificate; or
49.1    (3) a certificate from the dean of an accredited or approved college of veterinary
49.2medicine stating that the applicant is a student in good standing expecting to be graduated
49.3at the completion of the current academic year of the college in which the applicant is
49.5    The application shall contain the information and material required by subdivision
49.62 and any other information that the board may, in its sound judgment, require. The
49.7application shall be filed with the board at least 60 days before the date of the examination.
49.8If the board deems it advisable, it may require that such application be verified by the
49.9oath of the applicant.

49.10    Sec. 35. Minnesota Statutes 2006, section 156.02, subdivision 2, is amended to read:
49.11    Subd. 2. Required with application. Every application shall contain the following
49.12information and material:
49.13    (1) the application fee set by the board in the form of a check or money order payable
49.14to the board, which fee is not returnable in the event permission to take the examination
49.15is denied for good cause;
49.16    (2) a copy of a diploma from an accredited or approved college of veterinary
49.17medicine or a certificate from the dean or secretary of an accredited or approved college of
49.18veterinary medicine showing the time spent in the school and the date when the applicant
49.19was duly and regularly graduated or will duly and regularly graduate or verification of
49.20ECFVG or PAVE certification;
49.21    (3) affidavits of at least two veterinarians and three adults who are not related to
49.22the applicant setting forth how long a time, when, and under what circumstances they
49.23have known the applicant, and any other facts as may be proper to enable the board to
49.24determine the qualifications of the applicant; and
49.25    (4) if the applicant has served in the armed forces, a copy of discharge papers.

49.26    Sec. 36. Minnesota Statutes 2006, section 156.04, is amended to read:
49.28    The Board of Veterinary Medicine shall issue to every applicant who has successfully
49.29passed the required examination, who has received a diploma conferring the degree of
49.30doctor of veterinary medicine or an equivalent degree from an accredited or approved
49.31college of veterinary medicine or an ECFVG or PAVE certificate, and who shall have been
49.32adjudged to be duly qualified to practice veterinary medicine, a license to practice.

49.33    Sec. 37. Minnesota Statutes 2006, section 156.072, subdivision 2, is amended to read:
49.34    Subd. 2. Required with application. Such doctor of veterinary medicine shall
49.35accompany the application by the following:
50.1    (1) a copy of a diploma from an accredited or approved college of veterinary
50.2medicine or certification from the dean, registrar, or secretary of an accredited or approved
50.3college of veterinary medicine attesting to the applicant's graduation from an accredited
50.4or approved college of veterinary medicine, or a certificate of satisfactory completion of
50.5the ECFVG or PAVE program.
50.6    (2) affidavits of two licensed practicing doctors of veterinary medicine residing in
50.7the United States or Canadian licensing jurisdiction in which the applicant is currently
50.8practicing, attesting that they are well acquainted with the applicant, that the applicant is a
50.9person of good moral character, and has been actively engaged in practicing or teaching in
50.10such jurisdiction for the period above prescribed;
50.11    (3) a certificate from the regulatory agency having jurisdiction over the conduct of
50.12practice of veterinary medicine that such applicant is in good standing and is not the
50.13subject of disciplinary action or pending disciplinary action;
50.14    (4) a certificate from all other jurisdictions in which the applicant holds a currently
50.15active license or held a license within the past ten years, stating that the applicant is and
50.16was in good standing and has not been subject to disciplinary action;
50.17    (5) in lieu of clauses (3) and (4), certification from the Veterinary Information
50.18Verification Agency that the applicant's licensure is in good standing;
50.19    (6) a fee as set by the board in form of check or money order payable to the board,
50.20no part of which shall be refunded should the application be denied;
50.21    (7) score reports on previously taken national examinations in veterinary medicine,
50.22certified by the Veterinary Information Verification Agency; and
50.23    (8) if requesting waiver of examination, provide evidence of meeting licensure
50.24requirements in the state of the applicant's original licensure that were substantially equal
50.25to the requirements for licensure in Minnesota in existence at that time.

50.26    Sec. 38. Minnesota Statutes 2006, section 156.073, is amended to read:
50.27156.073 TEMPORARY PERMIT.
50.28    The board may issue without examination a temporary permit to practice veterinary
50.29medicine in this state to a person who has submitted an application approved by the
50.30board for license pending examination, and holds a doctor of veterinary medicine degree
50.31or an equivalent degree from an approved or accredited college of veterinary medicine
50.32or an ECFVG or PAVE certification. The temporary permit shall expire the day after
50.33publication of the notice of results of the first examination given after the permit is
50.34issued. No temporary permit may be issued to any applicant who has previously failed
50.35the national examination and is currently not licensed in any licensing jurisdiction of the
50.36United States or Canada or to any person whose license has been revoked or suspended
51.1or who is currently subject to a disciplinary order in any licensing jurisdiction of the
51.2United States or Canada.

51.3    Sec. 39. Minnesota Statutes 2006, section 156.12, subdivision 2, is amended to read:
51.4    Subd. 2. Authorized activities. No provision of this chapter shall be construed to
51.6    (a) a person from rendering necessary gratuitous assistance in the treatment of any
51.7animal when the assistance does not amount to prescribing, testing for, or diagnosing,
51.8operating, or vaccinating and when the attendance of a licensed veterinarian cannot be
51.10    (b) a person who is a regular student in an accredited or approved college of
51.11veterinary medicine from performing duties or actions assigned by instructors or
51.12preceptors or working under the direct supervision of a licensed veterinarian;
51.13    (c) a veterinarian regularly licensed in another jurisdiction from consulting with a
51.14licensed veterinarian in this state;
51.15    (d) the owner of an animal and the owner's regular employee from caring for and
51.16administering to the animal belonging to the owner, except where the ownership of the
51.17animal was transferred for purposes of circumventing this chapter;
51.18    (e) veterinarians who are in compliance with subdivision 6 and who are employed by
51.19the University of Minnesota from performing their duties with the College of Veterinary
51.20Medicine, College of Agriculture, Agricultural Experiment Station, Agricultural Extension
51.21Service, Medical School, School of Public Health, or other unit within the university; or
51.22a person from lecturing or giving instructions or demonstrations at the university or in
51.23connection with a continuing education course or seminar to veterinarians or pathologists
51.24at the University of Minnesota Veterinary Diagnostic Laboratory;
51.25    (f) any person from selling or applying any pesticide, insecticide or herbicide;
51.26    (g) any person from engaging in bona fide scientific research or investigations which
51.27reasonably requires experimentation involving animals;
51.28    (h) any employee of a licensed veterinarian from performing duties other than
51.29diagnosis, prescription or surgical correction under the direction and supervision of the
51.30veterinarian, who shall be responsible for the performance of the employee;
51.31    (i) a graduate of a foreign college of veterinary medicine from working under the
51.32direct personal instruction, control, or supervision of a veterinarian faculty member of
51.33the College of Veterinary Medicine, University of Minnesota in order to complete the
51.34requirements necessary to obtain an ECFVG or PAVE certificate.

51.35    Sec. 40. Minnesota Statutes 2006, section 156.12, subdivision 4, is amended to read:
52.1    Subd. 4. Titles. It is unlawful for a person who has not received a professional
52.2degree from an accredited or approved college of veterinary medicine, or ECFVG or PAVE
52.3certification, to use any of the following titles or designations: Veterinary, veterinarian,
52.4animal doctor, animal surgeon, animal dentist, animal chiropractor, animal acupuncturist,
52.5or any other title, designation, word, letter, abbreviation, sign, card, or device tending to
52.6indicate that the person is qualified to practice veterinary medicine.

52.7    Sec. 41. Minnesota Statutes 2006, section 156.12, subdivision 6, is amended to read:
52.8    Subd. 6. Faculty licensure. (a) Veterinary Medical Center clinicians at the College
52.9of Veterinary Medicine, University of Minnesota, who are engaged in the practice of
52.10veterinary medicine as defined in subdivision 1 and who treat animals owned by clients of
52.11the Veterinary Medical Center must possess the same license required by other veterinary
52.12practitioners in the state of Minnesota except for persons covered by paragraphs (b) and (c).
52.13    (b) A specialty practitioner in a hard-to-fill faculty position who has been employed
52.14at the College of Veterinary Medicine, University of Minnesota, for five years or
52.15more prior to 2003 or is specialty board certified by the American Veterinary Medical
52.16Association or the European Board of Veterinary Specialization may be granted a specialty
52.17faculty Veterinary Medical Center clinician license which will allow the licensee to
52.18practice veterinary medicine in the state of Minnesota in the specialty area of the licensee's
52.19training and only within the scope of employment at the Veterinary Medical Center.
52.20    (c) A specialty practitioner in a hard-to-fill faculty position at the College of
52.21Veterinary Medicine, University of Minnesota, who has graduated from a board-approved
52.22foreign veterinary school may be granted a temporary faculty Veterinary Medical Center
52.23clinician license. The temporary faculty Veterinary Medical Center clinician license
52.24expires in two years and allows the licensee to practice veterinary medicine as defined
52.25in subdivision 1 and treat animals owned by clients of the Veterinary Medical Center.
52.26The temporary faculty Veterinary Medical Center clinician license allows the licensee to
52.27practice veterinary medicine in the state of Minnesota in the specialty area of the licensee's
52.28training and only within the scope of employment at the Veterinary Medical Center while
52.29under the direct supervision of a veterinarian currently licensed and actively practicing
52.30veterinary medicine in Minnesota, as defined in section 156.04. The direct supervising
52.31veterinarian shall not have any current or past conditions, restrictions, or probationary
52.32status imposed on the veterinarian's license by the board within the past five years. The
52.33holder of a temporary faculty Veterinary Medical Center clinician license who is enrolled
52.34in a PhD program may apply for up to two additional consecutive two-year extensions
52.35of an expiring temporary faculty Veterinary Medical Center clinician license. Any other
52.36holder of a temporary faculty Veterinary Medical Center clinician license may apply for
53.1one two-year extension of the expiring temporary faculty Veterinary Medical Center
53.2clinician license. Temporary faculty Veterinary Medical Center clinician licenses that are
53.3allowed to expire may not be renewed. The board shall grant an extension to a licensee
53.4who demonstrates suitable progress toward completing the requirements of their academic
53.5program, specialty board certification, or full licensure in Minnesota by a graduate of a
53.6foreign veterinary college.
53.7    (d) Temporary and specialty faculty Veterinary Medical Center clinician licensees
53.8must abide by all the laws governing the practice of veterinary medicine in the state
53.9of Minnesota and are subject to the same disciplinary action as any other veterinarian
53.10licensed in the state of Minnesota.
53.11    (e) The fee for a license issued under this subdivision is the same as for a regular
53.12license to practice veterinary medicine in Minnesota. License payment deadlines, late
53.13payment fees, and other license requirements are also the same as for regular licenses.

53.14    Sec. 42. Minnesota Statutes 2006, section 156.15, subdivision 2, is amended to read:
53.15    Subd. 2. Service. Service of an order under this section is effective if the order is
53.16served on the person or counsel of record personally or by certified United States mail to
53.17the most recent address provided to the board for the person or counsel of record.

53.18    Sec. 43. Minnesota Statutes 2006, section 156.16, subdivision 3, is amended to read:
53.19    Subd. 3. Dispensing. "Dispensing" means distribution of veterinary prescription
53.20drugs or over-the-counter drugs for extra-label use or human drugs for extra-label use by a
53.21person licensed as a pharmacist by the Board of Pharmacy or a person licensed by the
53.22Board of Veterinary Medicine.

53.23    Sec. 44. Minnesota Statutes 2006, section 156.16, subdivision 10, is amended to read:
53.24    Subd. 10. Prescription. "Prescription" means an order from a veterinarian to a
53.25pharmacist or another veterinarian authorizing the dispensing of a veterinary prescription
53.26drug drugs, human drugs for extra-label use, or over-the counter drugs for extra-label use
53.27to a client for use on or in a patient.

53.28    Sec. 45. Minnesota Statutes 2006, section 156.18, subdivision 1, is amended to read:
53.29    Subdivision 1. Prescription. (a) A person may not dispense a veterinary
53.30prescription drug to a client without a prescription or other veterinary authorization. A
53.31person may not make extra-label use of an animal or human drug for an animal without a
53.32prescription from a veterinarian. A veterinarian or the veterinarian's authorized employee
53.33may dispense a veterinary prescription drug to drugs, human drugs for extra-label use, or
53.34an over-the-counter drug for extra-label use by a client or oversee the extra-label use of
53.35a veterinary drug directly by a client without a separate written prescription, providing
54.1there is documentation of the prescription in the medical record and there is an existing
54.2veterinarian-client-patient relationship. The prescribing veterinarian must monitor the use
54.3of veterinary prescription drugs, human drugs for extra-label use, or over-the-counter
54.4drugs for extra-label use by a client.
54.5    (b) A veterinarian may dispense prescription veterinary drugs and prescribe and
54.6dispense extra-label use drugs to a client without personally examining the animal if
54.7a bona fide veterinarian-client-patient relationship exists and in the judgment of the
54.8veterinarian the client has sufficient knowledge to use the drugs properly.
54.9    (c) A veterinarian may issue a prescription or other veterinary authorization by oral or
54.10written communication to the dispenser, or by computer connection. If the communication
54.11is oral, the veterinarian must enter it into the patient's record. The dispenser must record
54.12the veterinarian's prescription or other veterinary authorization within 72 hours.
54.13    (d) A prescription or other veterinary authorization must include:
54.14    (1) the name, address, and, if written, the signature of the prescriber;
54.15    (2) the name and address of the client;
54.16    (3) identification of the species for which the drug is prescribed or ordered;
54.17    (4) the name, strength, and quantity of the drug;
54.18    (5) the date of issue;
54.19    (6) directions for use; and
54.20    (7) withdrawal time., if applicable; and
54.21    (8) number of authorized refills.
54.22    (e) A veterinarian may, in the course of professional practice and an existing
54.23veterinarian-client-patient relationship, prepare medicaments that combine drugs approved
54.24by the United States Food and Drug Administration and other legally obtained ingredients
54.25with appropriate vehicles.
54.26    (f) A veterinarian or a bona fide employee of a veterinarian may dispense veterinary
54.27prescription drugs to a person on the basis of a prescription issued by a licensed
54.28veterinarian. The provisions of paragraphs (c) and (d) apply.
54.29    (g) This section does not limit the authority of the Minnesota Racing Commission to
54.30regulate veterinarians providing services at a licensed racetrack.

54.31    Sec. 46. Minnesota Statutes 2006, section 156.18, subdivision 2, is amended to read:
54.32    Subd. 2. Label of dispensed veterinary drugs. (a) A veterinarian or the
54.33veterinarian's authorized agent or employee dispensing a veterinary prescription drug
54.34or prescribing the extra-label use of an over-the-counter drug, an over-the-counter drug
54.35for extra-label use, or a human drug for extra-label use must provide written information
54.36which includes the name and address of the veterinarian, date of filling, species of patient,
55.1name or names of drug, strength of drug or drugs, directions for use, withdrawal time,
55.2and cautionary statements, if any, appropriate for the drug.
55.3    (b) If the veterinary drug has been prepared, mixed, formulated, or packaged by the
55.4dispenser, all of the information required in paragraph (a) must be provided on a label
55.5affixed to the container.
55.6    (c) If the veterinary drug is in the manufacturer's original package, the information
55.7required in paragraph (a) must be supplied in writing but need not be affixed to the
55.8container. Information required in paragraph (a) that is provided by the manufacturer on
55.9the original package does not need to be repeated in the separate written information.
55.10Written information required by this paragraph may be written on the sales invoice.

55.11    Sec. 47. Minnesota Statutes 2006, section 156.19, is amended to read:
55.12156.19 EXTRA-LABEL USE.
55.13    A person, other than a veterinarian or a person working under the control an
55.14employee of a veterinarian, must not make extra-label use of a veterinary drug in or
55.15on a food-producing animal, unless permitted by the prescription of a veterinarian. A
55.16veterinarian may prescribe the extra-label use of a veterinary drug if:
55.17    (1) the veterinarian makes a careful medical diagnosis within the context of a valid
55.18veterinarian-client-patient relationship;
55.19    (2) the veterinarian determines that there is no marketed drug specifically labeled to
55.20treat the condition diagnosed, or that drug therapy as recommended by the labeling has, in
55.21the judgment of the attending veterinarian, been found to be clinically ineffective;
55.22    (3) the veterinarian recommends procedures to ensure that the identity of the treated
55.23animal will be carefully maintained; and
55.24    (4) the veterinarian prescribes a significantly extended time period for drug
55.25withdrawal before marketing meat, milk, or eggs.; and
55.26    (5) the veterinarian has met the criteria established in Code of Federal Regulations,
55.27title 21, part 530, which define the extra-label use of medication in or on animals.

55.28    Sec. 48. Minnesota Statutes 2006, section 198.075, is amended to read:
55.31    Except as provided in this section, no commissary privileges including food, laundry
55.32service, janitorial service, and household supplies shall be furnished to any employee of
55.33the Minnesota veterans homes. An employee of the Minnesota veterans homes who works
55.34a second shift that is consecutive with a regularly scheduled shift may be allowed one free
55.35meal at the veterans home on the day of that extra shift.

56.1    Sec. 49. Minnesota Statutes 2006, section 256B.0625, subdivision 14, is amended to
56.3    Subd. 14. Diagnostic, screening, and preventive services. (a) Medical assistance
56.4covers diagnostic, screening, and preventive services.
56.5    (b) "Preventive services" include services related to pregnancy, including:
56.6    (1) services for those conditions which may complicate a pregnancy and which may
56.7be available to a pregnant woman determined to be at risk of poor pregnancy outcome;
56.8    (2) prenatal HIV risk assessment, education, counseling, and testing; and
56.9    (3) alcohol abuse assessment, education, and counseling on the effects of alcohol
56.10usage while pregnant. Preventive services available to a woman at risk of poor pregnancy
56.11outcome may differ in an amount, duration, or scope from those available to other
56.12individuals eligible for medical assistance.
56.13    (c) "Screening services" include, but are not limited to, blood lead tests. Screening
56.14services also include, for children with blood lead levels equal to or greater than five
56.15micrograms of lead per deciliter of whole blood, environmental investigations to
56.16determine the source of lead exposure. Reimbursement is limited to a health professional's
56.17time and activities during an on-site investigation of a child's home or primary residence.

56.18    Sec. 50. Minnesota Statutes 2006, section 256B.0625, is amended by adding a
56.19subdivision to read:
56.20    Subd. 49. Lead risk assessments. (a) Effective October 1, 2007, or six months after
56.21federal approval, whichever is later, medical assistance covers lead risk assessments
56.22provided by a lead risk assessor who is licensed by the commissioner of health under
56.23section 144.9505 and employed by an assessing agency as defined in section 144.9501.
56.24Medical assistance covers a onetime on-site investigation of a recipient's home or primary
56.25residence to determine the existence of lead so long as the recipient is under the age
56.26of 21 and has a venous blood lead level specified in section 144.9504, subdivision 2,
56.27paragraph (a).
56.28    (b) Medical assistance reimbursement covers the lead risk assessor's time to
56.29complete the following activities:
56.30    (1) gathering samples;
56.31    (2) interviewing family members;
56.32    (3) gathering data, including meter readings; and
56.33    (4) providing a report with the results of the investigation and options for reducing
56.34lead-based paint hazards.
56.35    Medical assistance coverage of lead risk assessment does not include testing of
56.36environmental substances such as water, paint, or soil or any other laboratory services.
57.1Medical assistance coverage of lead risk assessments is not included in the capitated
57.2services for children enrolled in health plans through the prepaid medical assistance
57.3program and the MinnesotaCare program.
57.4    (c) Payment for lead risk assessment must be cost-based and must meet the criteria
57.5for federal financial participation under the Medicaid program. The rate must be based
57.6on allowable expenditures from cost information gathered. Under section 144.9507,
57.7subdivision 5, federal medical assistance funds may not replace existing funding for
57.8lead-related activities. The nonfederal share of costs for services provided under this
57.9subdivision must be from state or local funds and is the responsibility of the agency
57.10providing the risk assessment. Eligible expenditures for the nonfederal share of costs may
57.11not be made from federal funds or funds used to match other federal funds. Any federal
57.12disallowances are the responsibility of the agency providing risk assessment services.

57.13    Sec. 51. [325.172] BISPHENOL-A IN PRODUCTS FOR CHILDREN.
57.14    Subd. 1. Bisphenol-A and phthalates committee. The commissioner of health
57.15shall create a committee under the direction of the environmental health division of the
57.16Department of Health to study the scientific literature and make recommendations to the
57.17legislature on the health impact of bisphenol-A and phthalates on children in products
57.18intended for use by young children, including, but not limited to, toys, pacifiers, baby
57.19bottles, and teethers, and report back by January 15, 2008. The committee shall also
57.20identify least harmful alternatives. Of the seven committee members at least one shall be a
57.21representative of the Department of Health, one shall be a representative of environmental
57.22health sciences research, one shall be a representative of the Minnesota Nurses
57.23Association, one shall be a representative of environmental health consumer advocates,
57.24one shall be a member of a children's product manufacturer's association, and one shall be
57.25a representative of the University of Minnesota, chemical plastics research department.
57.26    Subd. 2. Definitions. For the purposes of this section, the following terms have
57.27the meanings given them:
57.28    (a) "Toy" means all products designed or intended by the manufacturer to be used by
57.29children when they play.
57.30    (b) "Child care article" means all products designed or intended by the manufacturer
57.31to facilitate sleep, relaxation, or the feeding of children or to help children with sucking or

58.1    Subdivision 1. Definitions. For the purposes of sections 325E.386 to 325E.388,
58.2the terms in this section have the meanings given them.
58.3    Subd. 2. Commercial decabromodiphenyl ether. "Commercial
58.4decabromodiphenyl ether" means the chemical mixture of decabromodiphenyl ether,
58.5including associated polybrominated diphenyl ether impurities not intentionally added.
58.6    Subd. 3. Commissioner. "Commissioner" means the commissioner of the Pollution
58.7Control Agency.
58.8    Subd. 4. Manufacturer. "Manufacturer" means any person, firm, association,
58.9partnership, corporation, governmental entity, organization, or joint venture that produces
58.10a product containing polybrominated diphenyl ethers or an importer or domestic
58.11distributor of a noncomestible product containing polybrominated diphenyl ethers.
58.12    Subd. 5. Polybrominated diphenyl ethers or PBDE's. "Polybrominated diphenyl
58.13ethers" or "PBDE's" means chemical forms that consist of diphenyl ethers bound with
58.14bromine atoms. Polybrominated diphenyl ethers include, but are not limited to, the
58.15three primary forms of the commercial mixtures known as pentabromodiphenyl ether,
58.16octabromodiphenyl ether, and decabromodiphenyl ether.
58.17    Subd. 6. Retailer. "Retailer" means a person who offers a product for sale at retail
58.18through any means, including, but not limited to, remote offerings such as sales outlets,
58.19catalogs, or the Internet, but does not include a sale that is a wholesale transaction with a
58.20distributor or a retailer.
58.21    Subd. 7. Used product. "Used product" means any product that has been previously
58.22owned, purchased, or sold in commerce. Used product does not include any product
58.23manufactured after January 1, 2008.

58.24    Sec. 53. [325E.386] PRODUCTS CONTAINING CERTAIN
58.26    Subdivision 1. Penta and octabromodiphenyl ethers. Except as provided in
58.27subdivision 3, beginning January 1, 2008, a person may not manufacture, process, or
58.28distribute in commerce a product or flame-retardant part of a product containing more
58.29than one-tenth of one percent of pentabromodiphenyl ether or octabromodiphenyl ether
58.30by mass.
58.31    Subd. 2. Exemptions. The following products containing polybrominated diphenyl
58.32ethers are exempt from subdivision 1:
58.33    (1) the sale or distribution of any used transportation vehicle with component parts
58.34containing polybrominated diphenyl ethers;
59.1    (2) the sale or distribution of any used transportation vehicle parts or new
59.2transportation vehicle parts manufactured before January 1, 2008, that contain
59.3polybrominated diphenyl ethers;
59.4    (3) the manufacture, sale, repair, distribution, maintenance, refurbishment, or
59.5modification of equipment containing polybrominated diphenyl ethers and used primarily
59.6for military or federally funded space program applications. This exemption does not
59.7cover consumer-based goods with broad applicability;
59.8    (4) the sale or distribution by a business, charity, public entity, or private party of
59.9any used product containing polybrominated diphenyl ethers;
59.10    (5) the manufacture, sale, or distribution of new carpet cushion made from recycled
59.11foam containing more than one-tenth of one percent penta polybrominated diphenyl
59.12ether; or
59.13    (6) medical devices.
59.14    In-state retailers in possession of products on January 1, 2008, that are banned for
59.15sale under subdivision 1 may exhaust their stock through sales to the public. Nothing in
59.16this section restricts the ability of a manufacturer, importer, or distributor from transporting
59.17products containing polybrominated diphenyl ethers through the state, or storing such
59.18products in the state for later distribution outside the state.

59.20    Subdivision 1. Commissioner duties. The commissioner in consultation
59.21with the commissioners of health and public safety shall review uses of commercial
59.22decabromodiphenyl ether, availability of technically feasible and safer alternatives, fire
59.23safety and any evidence regarding the potential harm to public health and the environment
59.24posed by commercial decabromodiphenyl ether and the alternatives. The commissioner
59.25must consult with key stakeholders. The commissioner must also review the findings from
59.26similar state and federal agencies and must report their findings and recommendations to
59.27the appropriate committees of the legislature no later than January 15, 2008.
59.28    Subd. 2. State procurement. By January 1, 2008, the commissioner of
59.29administration shall make available for purchase and use by all state agencies only
59.30equipment, supplies, and other products that do not contain polybrominated diphenyl
59.31ethers, unless exempted under section 325E.386, subdivision 2.

59.32    Sec. 55. [325E.388] PENALTIES.
59.33    A manufacturer who violates sections 325E.386 to 325E.388 is subject to a
59.34civil penalty not to exceed $1,000 for each violation in the case of a first offense. A
59.35manufacturer is subject to a civil penalty not to exceed $5,000 for each repeat offense.
60.1Penalties collected under this section must be used by the commissioner to implement
60.2and enforce this section.

60.3    Sec. 56. Laws 2005, First Special Session chapter 4, article 9, section 3, subdivision 2,
60.4is amended to read:
Subd. 2.Community and Family Health
Summary by Fund
State Government
Special Revenue
Health Care Access
Federal TANF
60.13Family Planning Base Reduction. Base
60.14level funding for the family planning
60.15special projects grant program is reduced
60.16by $1,877,000 each year of the biennium
60.17beginning July 1, 2007, provided that
60.18this reduction shall only take place
60.19upon full implementation of the family
60.20planning project section of the 1115 waiver.
60.21Notwithstanding Minnesota Statutes, section
60.22145.925, the commissioner shall give priority
60.23to community health care clinics providing
60.24family planning services that either serve a
60.25high number of women who do not qualify
60.26for medical assistance or are unable to
60.27participate in the medical assistance program
60.28as a medical assistance provider when
60.29allocating the remaining appropriations.
60.30Notwithstanding section 15, this paragraph
60.31shall not expire.
60.32Shaken Baby Video. Of the state
60.33government special revenue fund
60.34appropriation, $13,000 in 2006 is
60.35appropriated to the commissioner of health
60.36to provide a video to hospitals on shaken
61.1baby syndrome. The commissioner of health
61.2shall assess a fee to hospitals to cover the
61.3cost of the approved shaken baby video and
61.4the revenue received is to be deposited in the
61.5state government special revenue fund.

61.7    The commissioner of health, in conjunction with the commissioner of the Pollution
61.8Control Agency, shall apply for federal funding to renew and expand the state's
61.9environmental justice mapping capacity in order to promote public health tracking. The
61.10commissioner shall coordinate the project with the Pollution Control Agency and the
61.11Department of Agriculture in order to explore possible links between environmental health
61.12and toxic exposures and to help create a system for environmental public health tracking.
61.13The commissioner shall also make recommendations to the legislature for additional
61.14sources of funding within the state.
61.15EFFECTIVE DATE.This section is effective the day following final enactment.

61.17    The legislature hereby finds that hearing loss occurs in newborn infants more
61.18frequently than any other health condition for which newborn infant screening is required.
61.19Early detection of hearing loss in a child and early intervention and treatment has been
61.20demonstrated to be highly effective in facilitating a child's healthy development in a
61.21manner consistent with the child's age, language acquisition, and cognitive ability.
61.22Without early hearing detection and intervention, children with hearing loss experience
61.23serious delays in language acquisition and social and cognitive development. With
61.24appropriate testing and identification of newborn infants, hearing loss screening will
61.25facilitate early intervention and treatment and will serve the public purpose of promoting
61.26the healthy development of children.
61.27    For these reasons, the legislature hereby determines that it is beneficial and in the
61.28best interests of the development of the children of the state of Minnesota that newborn
61.29infants' hearing be screened.

61.30    Sec. 59. INFORMATION SHARING.
61.31    By August 1, 2007, the commissioner of health, the Pollution Control Agency, the
61.32commissioner of agriculture, and the University of Minnesota are requested to jointly
61.33develop and sign a memorandum of understanding declaring their intent to share new
61.34and existing environmental hazard, exposure, and health outcome data, consistent with
62.1applicable data practices laws, and to cooperate and communicate effectively to ensure
62.2sufficient clarity and understanding of the data between these organizations.

62.5    The commissioner of health, in cooperation with the utility that owns a facility in
62.6Monticello, shall issue a report detailing where routine radiation releases go, and the
62.7health impacts of the radiation emissions on affected communities. By January 1, 2008,
62.8the report shall be distributed to house and senate committees having jurisdiction over
62.9public health and to all communities that are part of the emergency response planning.

62.11    Subdivision 1. Purpose. Recognizing that scented products may trigger asthma or
62.12chemical sensitivity reactions in students and school staff, which can contribute to learning
62.13and breathing problems, the commissioner of health shall develop a fragrance-free schools
62.14education pilot project.
62.15    Subd. 2. Education. The commissioner of health, in collaboration with the
62.16commissioner of education and the Minneapolis Board of Education, shall establish a
62.17working group composed of at least three students, two teachers, one school administrator,
62.18and one member of the Minneapolis Board of Education to recommend an education
62.19campaign in Minneapolis public schools to inform students and parents about the
62.20potentially harmful effects of the use of fragrance products on sensitive students and
62.21school personnel in Minneapolis schools. The commissioner shall report findings to the
62.22legislature by February 1, 2008.
62.23EFFECTIVE DATE.This section is effective the day following final enactment.

62.24    Sec. 62. LINDANE COMMITTEE.
62.25    The commissioner of health shall create a committee of stakeholders, including
62.26at least one environmental health research scientist and at least one parent consumer
62.27advocate, to review the scientific literature and make recommendations to the legislature
62.28on the health impact of Lindane on children and report back by January 15, 2008.

62.30    The commissioner of human services shall ensure that testing for arsenic under
62.31section 1, subdivision 3, is covered under medical assistance.

62.33The commissioner of health, in consultation with the Department of Human
62.34Services; cities of the first class; health care providers; and other interested parties shall
63.1conduct a study to evaluate blood lead testing methods used to confirm elevated blood
63.2lead status. The study shall examine and/or develop:
63.3(1) the false positive rate of capillary tests for children less than 72 months old;
63.4(2) current protocols for conducting capillary testing, including filter paper
63.6(3) existing guidelines and regulations from other states and federal agencies
63.7regarding lead testing;
63.8(4) recommendations regarding the use of capillary tests to initiate environmental
63.9investigations and case management, including number and timing of tests and fiscal
63.10implications for state and local lead programs; and
63.11(5) recommendations regarding reducing the state mandatory intervention to ten
63.12micrograms of lead per deciliter of whole blood.
63.13The commissioner shall submit the results of the study and any recommendations,
63.14including any necessary legislative changes, to the legislature by February 15, 2008.

63.15    Sec. 65. REVISOR'S INSTRUCTION.
63.16    The revisor of statutes shall change the range reference "144.9501 to 144.9509"
63.17to "144.9501 to 144.9512" wherever the reference appears in Minnesota Statutes and
63.18Minnesota Rules.

63.19    Sec. 66. REPEALER.
63.20Laws 2004, chapter 288, article 6, section 27, is repealed.

63.21ARTICLE 3

63.24    The amounts shown in this section summarize direct appropriations, by fund, made
63.25in this article.

Sec. 2. HOUSING.
63.31    The sums shown in the columns marked "Appropriations" are appropriated to the
63.32agencies and for the purposes specified. The appropriations are from the general fund, or
63.33another named fund, and are available for the fiscal years indicated for each purpose. The
63.34figures "2008" and "2009" used in this act mean that the appropriations listed under them
63.35are available for the fiscal year ending June 30, 2008, or June 30, 2009, respectively. "The
64.1first year" is fiscal year 2008. "The second year" is fiscal year 2009. "The biennium" is
64.2fiscal years 2008 and 2009. Appropriations for the fiscal year ending June 30, 2007, are
64.3effective the day following final enactment.
Available for the Year
Ending June 30

Subdivision 1.Total Appropriation
Appropriations by Fund
64.14This appropriation is for transfer to the
64.15housing development fund. The amounts
64.16that may be spent from this appropriation
64.17for certain programs are specified in the
64.18following subdivisions. Except as otherwise
64.19indicated, this transfer is part of the agency's
64.20permanent budget base.
64.21Of this amount, $3,075,000 the first year
64.22and $3,075,000 the second year are onetime
64.23appropriations from the state's federal TANF
64.24block grant under Title I of Public Law
64.25Number 104-193 to the commissioner of
64.26human services, to reimburse the housing
64.27development fund for assistance under
64.28the programs for families receiving TANF
64.29assistance under the MFIP program. The
64.30commissioner of human services shall make
64.31monthly reimbursements to the housing
64.32development fund. The commissioner
64.33of human services shall not make any
64.34reimbursement which the commissioner
64.35determines would be subject to a penalty
64.36under Code of Federal Regulations, section
65.1262.1. If the appropriation in either year is
65.2insufficient, the appropriation for the other
65.3year is available.
Subd. 2.Economic Development and Housing
65.6(a) $17,808,000 the first year and $9,622,000
65.7the second year are for the economic
65.8development and housing challenge program
65.9under Minnesota Statutes, section 462A.33,
65.10for housing that:
65.11(i) conserves energy and utilizes sustainable,
65.12healthy building materials;
65.13(ii) preserves sensitive natural areas and
65.14open spaces and minimizes the need for new
65.16(iii) is accessible to jobs and services through
65.17integration with transportation or transit
65.18systems; and
65.19(iv) expands the mix of housing choices in
65.20a community by diversifying the levels of
65.21housing affordability.
65.22The agency may fund demonstration projects
65.23that have unique approaches to achieving the
65.24housing described above.
65.25(b) The base is reduced by $3,407,000 each
65.26year in fiscal year 2010 and fiscal year 2011.
Subd. 3.Housing Trust Fund
65.28$15,195,000 the first year and $11,945,000
65.29the second year are for the housing trust fund
65.30account created under Minnesota Statutes,
65.31section 462A.201, for the purposes of that
65.32section. Of this amount, $1,500,000 the first
65.33year and $1,500,000 in the second year is a
65.34onetime appropriation from the state's federal
66.1TANF block grant. The base is reduced by
66.2$3,390,000 each year in fiscal year 2010 and
66.3fiscal year 2011.
Subd. 4.Bridges Rental Assistance for
Mentally Ill
66.6$5,150,000 the first year and $5,150,000
66.7the second year are for a rental housing
66.8assistance program for persons with a mental
66.9illness or families with an adult member with
66.10a mental illness under Minnesota Statutes,
66.11section 462A.2097. The base is reduced by
66.12$1,650,000 each year in fiscal year 2010 and
66.13fiscal year 2011.
Subd. 5.Family Homeless Prevention
66.15$7,565,000 the first year and $7,565,000
66.16the second year are for family homeless
66.17prevention and assistance programs under
66.18Minnesota Statutes, section 462A.204. Of
66.19this amount, $1,575,000 in the first year
66.20and $1,575,000 in the second year is a
66.21onetime appropriation from the state's federal
66.22TANF block grant. The base is reduced by
66.23$3,800,000 each year in fiscal year 2010 and
66.24fiscal year 2011.
Subd. 6.Home Ownership Assistance Fund
66.26$1,885,000 the first year and $1,885,000
66.27the second year are for the home ownership
66.28assistance program under Minnesota
66.29Statutes, section 462A.21, subdivision 8.
66.30The base is reduced by $1,000,000 each year
66.31in fiscal year 2010 and fiscal year 2011.
Subd. 7.Affordable Rental Investment Fund
66.33$11,496,000 the first year and $8,996,000
66.34the second year are for the affordable rental
67.1investment fund program under Minnesota
67.2Statutes, section 462A.21, subdivision 8b.
67.3Of this amount, $2,500,000 the first year is a
67.4onetime appropriation.
67.5This appropriation is to finance the
67.6acquisition, rehabilitation, and debt
67.7restructuring of federally assisted rental
67.8property and for making equity take-out loans
67.9under Minnesota Statutes, section 462A.05,
67.10subdivision 39. The owner of the federally
67.11assisted rental property must agree to
67.12participate in the applicable federally assisted
67.13housing program and to extend any existing
67.14low-income affordability restrictions on the
67.15housing for the maximum term permitted.
67.16The owner must also enter into an agreement
67.17that gives local units of government,
67.18housing and redevelopment authorities,
67.19and nonprofit housing organizations the
67.20right of first refusal if the rental property
67.21is offered for sale. Priority must be given
67.22among comparable federally assisted rental
67.23properties to properties with the longest
67.24remaining term under an agreement for
67.25federal rental assistance. Priority must also
67.26be given among comparable rental housing
67.27developments to developments that are or
67.28will be owned by local government units, a
67.29housing and redevelopment authority, or a
67.30nonprofit housing organization.
67.31This appropriation may also be used to
67.32finance the acquisition, rehabilitation, and
67.33debt restructuring of existing supportive
67.34housing properties. For purposes of this
67.35subdivision, "supportive housing" means
67.36affordable rental housing with links to
68.1services necessary for individuals, youth, and
68.2families with children to maintain housing
68.4Of this amount, $2,500,000 is appropriated
68.5for the purposes of financing the
68.6rehabilitation and operating costs to preserve
68.7public housing. For purposes of this
68.8subdivision, "public housing" is housing for
68.9low-income persons and households financed
68.10by the federal government and owned and
68.11operated by public housing authorities and
68.12agencies. Eligible public housing authorities
68.13must have a public housing assessment
68.14system rating of standard or above. Priority
68.15among comparable proposals must be given
68.16to proposals that maximize federal or local
68.17resources to finance the capital and operating
Subd. 8.Housing Rehabilitation and
68.21$5,657,000 the first year and $4,287,000 the
68.22second year are for the housing rehabilitation
68.23and accessibility program under Minnesota
68.24Statutes, section 462A.05, subdivisions 14a
68.25and 15a. The base is reduced by $629,000
68.26each year in fiscal year 2010 and fiscal year
Subd. 9.Urban Indian Housing Program
68.29$187,000 in the first year and $187,000 in
68.30the second year are for the urban Indian
68.31housing program under Minnesota Statutes,
68.32section 462A.07, subdivision 15. The base is
68.33reduced by $52,000 each year in fiscal year
68.342010 and fiscal year 2011.
Subd. 10.Tribal Indian Housing Program
69.1$1,683,000 in the first year and $1,683,000
69.2in the second year are for the tribal Indian
69.3housing program under Minnesota Statutes,
69.4section 462A.07, subdivision 14. The base is
69.5reduced by $468,000 each year in fiscal year
69.62010 and fiscal year 2011.
Subd. 11.Home Ownership Education,
Counseling, and Training
69.9$2,135,000 the first year and $2,135,000
69.10the second year are appropriated for the
69.11home ownership education, counseling, and
69.12training program under Minnesota Statutes,
69.13section 462A.209. The base is reduced by
69.14$1,460,000 each year in fiscal year 2010 and
69.15fiscal year 2011.Of this amount, $6,30,000
69.16the first year is for:
69.17(1) foreclosure prevention and assistance
69.18activities in communities that have mortgage
69.19foreclosure rates that exceed the statewide
69.20average foreclosure rate for the most recent
69.21quarter for which data is available; and
69.22(2) home buyer education and counseling
69.23activities by organizations that have
69.24experience working with emerging markets
69.25or partner with organizations with experience
69.26working with emerging markets and that have
69.27demonstrated a commitment to increasing the
69.28homeownership rate of emerging markets.
Subd. 12.Capacity Building Grants
69.30$820,000 for the biennium is for capacity
69.31building grants under Minnesota Statutes
69.32section 462A.21, subdivision 3b, to be used
69.33for continuum of care planning in greater
69.34Minnesota. This appropriation is the agency's
69.35base budget for this program.
70.1    Subd. 13. Grant for Hennepin County.
70.2$50,000 is a onetime appropriation in the
70.3first year for a grant to Hennepin County
70.4for collaboration with the Center for Urban
70.5and Regional Affairs at the University
70.6of Minnesota for the development of a
70.7predictive, data-driven model that can be
70.8used to identify at-risk properties in order to
70.9target resources to prevent foreclosure.

70.10    Sec. 4. Minnesota Statutes 2006, section 469.021, is amended to read:
70.11469.021 PREFERENCES.
70.12    As between applicants equally in need and eligible for occupancy of a dwelling
70.13and at the rent involved, preference shall be given to disabled veterans, persons with
70.14disabilities, and families of service persons who died in service and to families of veterans.
70.15In admitting families of low income to dwelling accommodations in any housing project an
70.16authority shall, as far as is reasonably practicable, give consideration to applications from
70.17families to which aid for dependent children is payable receiving assistance under chapter
70.18256J, and to resident families to whom public assistance or supplemental security income
70.19for the aged, blind, and disabled is payable, when those families are otherwise eligible."
70.20Amend the title accordingly